Skip Navigation
Skip to contents

Diabetes Metab J : Diabetes & Metabolism Journal

Search
OPEN ACCESS

Most cited

Page Path
HOME > Browse > Most cited
151 Most cited
Filter
Filter
Article category
Keywords
Publication year
Authors
Funded articles

From articles published in Diabetes & Metabolism Journal during the past two years (2023 ~ ).

Reviews
Guideline/Fact Sheet
Article image
2023 Clinical Practice Guidelines for Diabetes Mellitus of the Korean Diabetes Association
Jong Han Choi, Kyung Ae Lee, Joon Ho Moon, Suk Chon, Dae Jung Kim, Hyun Jin Kim, Nan Hee Kim, Ji A Seo, Mee Kyoung Kim, Jeong Hyun Lim, YoonJu Song, Ye Seul Yang, Jae Hyeon Kim, You-Bin Lee, Junghyun Noh, Kyu Yeon Hur, Jong Suk Park, Sang Youl Rhee, Hae Jin Kim, Hyun Min Kim, Jung Hae Ko, Nam Hoon Kim, Chong Hwa Kim, Jeeyun Ahn, Tae Jung Oh, Soo-Kyung Kim, Jaehyun Kim, Eugene Han, Sang-Man Jin, Won Suk Choi, Min Kyong Moon, Committee of Clinical Practice Guidelines, Korean Diabetes Association
Diabetes Metab J. 2023;47(5):575-594.   Published online September 26, 2023
DOI: https://doi.org/10.4093/dmj.2023.0282
  • 16,165 View
  • 1,460 Download
  • 58 Web of Science
  • 61 Crossref
AbstractAbstract PDFPubReader   ePub   
In May 2023, the Committee of Clinical Practice Guidelines of the Korean Diabetes Association published the revised clinical practice guidelines for Korean adults with diabetes and prediabetes. We incorporated the latest clinical research findings through a comprehensive systematic literature review and applied them in a manner suitable for the Korean population. These guidelines are designed for all healthcare providers nationwide, including physicians, diabetes experts, and certified diabetes educators who manage patients with diabetes or individuals at risk of developing diabetes. Based on recent changes in international guidelines and the results of a Korean epidemiological study, the recommended age for diabetes screening has been lowered. In collaboration with the relevant Korean medical societies, recently revised guidelines for managing hypertension and dyslipidemia in patients with diabetes have been incorporated into this guideline. An abridgment containing practical information on patient education and systematic management in the clinic was published separately.

Citations

Citations to this article as recorded by  
  • Educational Needs and Priorities of People with Diabetes and Healthcare Providers in South Korea: A Mixed-Methods Study
    Shinae Seo, Chun-Ja Kim, Hee Sun Kang, Elizabeth A. Schlenk
    Journal of Transcultural Nursing.2025; 36(2): 195.     CrossRef
  • Efficacy and safety of a fixed‐dose combination of dapagliflozin and linagliptin (AJU‐A51) in patients with type 2 diabetes mellitus: A multicentre, randomized, double‐blind, parallel‐group, placebo‐controlled phase III study
    Jun Hwa Hong, Myung Jin Kim, Kyung Wan Min, Jong Chul Won, Tae Nyun Kim, Byung‐Wan Lee, Jun Goo Kang, Jae Hyeon Kim, Jung Hwan Park, Bon Jeong Ku, Chang Beom Lee, Sang Yong Kim, Ho Sang Shon, Woo Je Lee, Joong‐Yeol Park
    Diabetes, Obesity and Metabolism.2025; 27(1): 81.     CrossRef
  • 1-Hour Postload Glucose: Early Screening for High Risk of Type 2 Diabetes in Koreans With Normal Fasting Glucose
    Min Jin Lee, Ji Hyun Bae, Ah Reum Khang, Dongwon Yi, Joo Yeon Kim, Su Hyun Kim, Dong Hee Kim, Dasol Kang, Sujin Park, Yun Kyung Jeon, Sang Soo Kim, Bo Hyun Kim, Mi Sook Yun, Yang Ho Kang
    The Journal of Clinical Endocrinology & Metabolism.2025; 110(4): 1076.     CrossRef
  • Management of Elderly Patients with Chronic Kidney Disease
    Yohan Park, Won Min Hwang
    Yonsei Medical Journal.2025; 66(2): 63.     CrossRef
  • Trends in prescribing sodium‐glucose cotransporter 2 inhibitors for individuals with type 2 diabetes with and without cardiovascular‐renal disease in South Korea, 2015–2021
    Kyoung Hwa Ha, Soyoung Shin, EunJi Na, Dae Jung Kim
    Journal of Diabetes Investigation.2025; 16(2): 215.     CrossRef
  • Short‐term efficacy and safety of metformin in individuals with type 2 diabetes and mild hepatic impairment: A propensity score‐matched real‐world study
    Seunghwan Baek, Jongseok Park, Jae‐Yong Chung, Soo Heon Kwak, Seonghae Yoon
    Diabetes, Obesity and Metabolism.2025; 27(3): 1580.     CrossRef
  • Quality of Life in Women With Gestational Diabetes Mellitus and Treatment Satisfaction Upon Intermittently Scanned Continuous Glucose Monitoring
    Sookyung Won, Hyeon Ji Kim, Jee Yoon Park, Kyung Joon Oh, Sung Hee Choi, Hak Chul Jang, Joon Ho Moon
    Journal of Korean Medical Science.2025;[Epub]     CrossRef
  • Glycemia Risk Index is Associated With Risk of Albuminuria Among Individuals With Type 1 Diabetes
    Ji Yoon Kim, Jee Hee Yoo, Nam Hoon Kim, Jae Hyeon Kim
    Journal of Diabetes Science and Technology.2025;[Epub]     CrossRef
  • An anonymized, de-identified registry study protocol to determine the effectiveness and safety of weight loss with enavogliflozin in patients with type 2 diabetes mellitus
    Hyunji Sang, Sunyoung Kim, Jiyoung Hwang, Selin Woo, Jaewon Kim, Dong Keon Yon, Sang Youl Rhee, Aleksandra Klisic
    PLOS ONE.2025; 20(1): e0315603.     CrossRef
  • Comparison of Clinical Outcomes Between Two Types of Dipeptidyl Peptidase-4 Inhibitors in Posttransplant Diabetes Mellitus in Kidney Transplantation Recipients: A Nationwide Population-Based Cohort Study in Korea
    Keun young Lee, Ga young Song, Min jun Seo, Sung hwa Kim, Dae Ryong Kang, Keunryul Park, Ji Teck Kim, Sang Wook Park, Jun Young Lee
    Transplantation Proceedings.2025; 57(2): 208.     CrossRef
  • Effects of e-health literacy on health-related quality of life in young adults with type 2 diabetes: Parallel mediation of diabetes self-efficacy and self-care behaviors
    Yura Jang, Youngran Yang
    Applied Nursing Research.2025; 82: 151917.     CrossRef
  • Effect of Glomerular Hyperfiltration on Incident Cardiovascular Disease in Patients with Type 2 Diabetes Mellitus
    Seung Min Chung, Inha Jung, Da Young Lee, So Young Park, Ji Hee Yu, Jun Sung Moon, Ji A. Seo, Kyung-Do Han, Nan Hee Kim
    Clinical Journal of the American Society of Nephrology.2025; 20(3): 410.     CrossRef
  • Development and Validation of a Machine Learning Algorithm for Predicting Diabetes Retinopathy in Patients With Type 2 Diabetes: Algorithm Development Study
    Sunyoung Kim, Jaeyu Park, Yejun Son, Hojae Lee, Selin Woo, Myeongcheol Lee, Hayeon Lee, Hyunji Sang, Dong Keon Yon, Sang Youl Rhee
    JMIR Medical Informatics.2025; 13: e58107.     CrossRef
  • Utility of Treatment Pattern Analysis Using a Common Data Model: A Scoping Review
    Eun-Gee Park, Min Jung Kim, Jinseo Kim, Kichul Shin, Borim Ryu
    Healthcare Informatics Research.2025; 31(1): 4.     CrossRef
  • Blood pressure levels and risk of end-stage renal disease in patients with type 2 diabetes who underwent percutaneous coronary intervention: a nationwide population-based study
    Hyunglae Kim, Yong-Moon Park, Seung-Hyun Ko, Yun-Jung Cho, Hyung Wook Kim, Yong Kyun Kim, Kyung-Do Han, Jae-Seung Yun, Kyuho Kim, Donggyu Moon
    Scientific Reports.2025;[Epub]     CrossRef
  • Study Design and Protocol for a Randomized Controlled Trial of Enavogliflozin to Evaluate Cardiorenal Outcomes in Type 2 Diabetes (ENVELOP)
    Nam Hoon Kim, Soo Lim, In-Kyung Jeong, Eun-Jung Rhee, Jun Sung Moon, Ohk-Hyun Ryu, Hyuk-Sang Kwon, Jong Chul Won, Sang Soo Kim, Sang Yong Kim, Bon Jeong Ku, Heung Yong Jin, Sin Gon Kim, Bong-Soo Cha
    Diabetes & Metabolism Journal.2025; 49(2): 225.     CrossRef
  • An overview of insulin therapy for the non‐specialist
    Philip D. Home
    Diabetes, Obesity and Metabolism.2025;[Epub]     CrossRef
  • Older Adults with Diabetes in Korea: Latest Clinical and Epidemiologic Trends
    Kyuho Kim, Bongseong Kim, Kyuna Lee, Yu-Bae Ahn, Seung-Hyun Ko, Sung Hee Choi, Kyungdo Han, Jae-Seung Yun
    Diabetes & Metabolism Journal.2025; 49(2): 183.     CrossRef
  • Effectiveness of adding glucagon-like peptide-1 receptor agonist on diabetes complications and mortality among basal insulin-treated people with type 2 diabetes: A real-world Korean study
    Kyoung Hwa Ha, Won Kim, Dong Han Kim, Dae Jung Kim
    Journal of Diabetes and its Complications.2025; 39(5): 108983.     CrossRef
  • Risk of Cardiovascular Disease According to the Precedence Relationship Between Hypertension and Diabetes Mellitus
    Junhee Park, Kyungdo Han, Kyuna Lee, Yoosoo Chang, Dong Wook Shin
    Healthcare.2025; 13(7): 796.     CrossRef
  • Electrocardiographic Changes in Patients with Type 2 Diabetes Mellitus—A Meta-Analysis
    Teodora-Gabriela Alexescu, Antonia Nechita, Paula Alexander, Mirela-Georgiana Perné, Mircea-Vasile Milaciu, George Ciulei, Ioana Para, Vasile Negrean, Ana-Florica Chiș, Doina-Adina Todea, Dan Vălean, Simina-Felicia Țărmure, Olga-Hilda Orășan
    Journal of Mind and Medical Sciences.2025; 12(1): 14.     CrossRef
  • Recent Updates on the Renoprotective Effects of Glucagon-Like Peptide 1 Receptor Agonists
    Hong Sang Choi, Eun Hui Bae
    The Korean Journal of Medicine.2025; 100(2): 61.     CrossRef
  • Association between the body mass index and risk of cardiovascular events in sodium‐glucose cotransporter 2 inhibitor users compared with dipeptidyl‐peptidase 4 inhibitor users: A nationwide cohort study in Korea
    Hwa Yeon Ko, Kyungyeon Jung, Yongtai Cho, Sungho Bea, Jae Hyun Bae, Young Min Cho, Sang Youl Rhee, Ju‐Young Shin
    Diabetes, Obesity and Metabolism.2025;[Epub]     CrossRef
  • Effectiveness and Safety of Oral Quadruple Combination Therapy in Patients with Type 2 Diabetes: A Systematic Review and Meta-Analysis
    Jaehyun Bae, Min Heui Yu, Minyoung Lee, Bong-Soo Cha, Byung-Wan Lee
    Endocrinology and Metabolism.2025; 40(2): 258.     CrossRef
  • Mortality in metabolic dysfunction-associated steatotic liver disease: A nationwide population-based cohort study
    Eugene Han, Byung-Wan Lee, Eun Seok Kang, Bong-Soo Cha, Sang Hoon Ahn, Yong-ho Lee, Seung Up Kim
    Metabolism.2024; 152: 155789.     CrossRef
  • Letter by In-Kyung Jeong Regarding Article, Trends in Prevalence of Hypertriglyceridemia and Related Factors in Korean Adults: A Serial Cross-Sectional Study
    In-Kyung Jeong
    Journal of Lipid and Atherosclerosis.2024; 13(1): 80.     CrossRef
  • Association between cardiovascular disease risk and incident type 2 diabetes mellitus in individuals with prediabetes: A retrospective cohort study
    Myung Jin Kim, Yun Kyung Cho, Chang Hee Jung, Woo Je Lee
    Diabetes Research and Clinical Practice.2024; 208: 111125.     CrossRef
  • Korea Hypertension Fact Sheet 2023: analysis of nationwide population-based data with a particular focus on hypertension in special populations
    Hyeon Chang Kim, Hokyou Lee, Hyeok-Hee Lee, Dasom Son, Minsung Cho, Sojung Shin, Yeeun Seo, Eun-Jin kim, Song Vogue Ahn, Sun Ha Jee, Sungha Park, Hae-Young Lee, Min Ho Shin, Sang-Hyun Ihm, Seung Won Lee, Jong Ku Park, Il Suh, Tae-Yong Lee
    Clinical Hypertension.2024;[Epub]     CrossRef
  • Diabetes Duration, Cholesterol Levels, and Risk of Cardiovascular Diseases in Individuals With Type 2 Diabetes
    Mee Kyoung Kim, Kyu Na Lee, Kyungdo Han, Seung-Hwan Lee
    The Journal of Clinical Endocrinology & Metabolism.2024; 109(12): e2317.     CrossRef
  • Effect of Adding Apolipoprotein B Testing on the Prevalence of Dyslipidemia and Risk of Cardiovascular Disease in the Korean Adult Population
    Rihwa Choi, Sang Gon Lee, Eun Hee Lee
    Metabolites.2024; 14(3): 169.     CrossRef
  • Fenofibrate to prevent amputation and reduce vascular complications in patients with diabetes: FENO-PREVENT
    Eu Jeong Ku, Bongseong Kim, Kyungdo Han, Seung-Hwan Lee, Hyuk-Sang Kwon
    Cardiovascular Diabetology.2024;[Epub]     CrossRef
  • A self-powered and supercapacitive microneedle continuous glucose monitoring system with a wide range of glucose detection capabilities
    Hye-Jun Kil, Jang Hyeon Kim, Kanghae Lee, Tae-Uk Kang, Ju-Hyun Yoo, Yong-ho Lee, Jin-Woo Park
    Biosensors and Bioelectronics.2024; 257: 116297.     CrossRef
  • Cardiorenal outcomes and mortality after sodium‐glucose cotransporter‐2 inhibitor initiation in type 2 diabetes patients with percutaneous coronary intervention history
    Jin Hwa Kim, Young Sang Lyu, BongSeong Kim, Mee Kyung Kim, Sang Yong Kim, Ki‐Hyun Baek, Ki‐Ho Song, Kyungdo Han, Hyuk‐Sang Kwon
    Diabetes, Obesity and Metabolism.2024; 26(7): 2567.     CrossRef
  • SGLT2i impact on HCC incidence in patients with fatty liver disease and diabetes: a nation-wide cohort study in South Korea
    Hyo Jung Cho, Eunyoung Lee, Soon Sun Kim, Jae Youn Cheong
    Scientific Reports.2024;[Epub]     CrossRef
  • The importance of diabetes mellitus in dental practice
    Nina Dimitrijević-Jovanović, Hristina Ugrinović, Radomir Mitić, Nevena Kalezić
    Galenika Medical Journal.2024; 3(9): 80.     CrossRef
  • Evaluation of glycemic response of ten local meals commonly consumed from Chad
    Zoufane Guedeungbe, Jean Paul Bayang, Benoît Bargui Koubala
    Journal of Agriculture and Food Research.2024; 17: 101251.     CrossRef
  • Glycemic Control and Oral Health Outcomes in Patients With Diabetes: Insights From a Nationwide Korean Survey
    Song-Yi Yu, Sun-Kyung Lee, Bumhee Yang, Hyun Lee, Hyun Jeong Jeon, Dong-Hwa Lee
    Journal of Korean Medical Science.2024;[Epub]     CrossRef
  • Efficacy and safety of albiglutide, a once-weekly glucagon-like peptide-1 receptor agonist, in patients with type 2 diabetes: A systematic review and meta-analysis
    A.B.M. Kamrul-Hasan, Deep Dutta, Lakshmi Nagendra, Saptarshi Bhattacharya, Rajiv Singla, Sanjay Kalra
    Medicine.2024; 103(25): e38568.     CrossRef
  • Longitudinal Analysis of Diabetes Mellitus Risk: Smoking Status and Smoking Cessation
    Da-Eun Sung, Seung-Jae Lee, Mi-Yeon Lee, Eun-Jung Rhee, Ki-Chul Sung
    Journal of Clinical Medicine.2024; 13(13): 3927.     CrossRef
  • Current type 2 diabetes guidelines: Individualized treatment and how to make the most of metformin
    Juliana C. N. Chan, Aimin Yang, Natural Chu, Elaine Chow
    Diabetes, Obesity and Metabolism.2024; 26(S3): 55.     CrossRef
  • Comprehensive management of polypharmacy in older patients with diabetes
    Kang Seo Park, Hea Min Yu
    Journal of the Korean Medical Association.2024; 67(7): 449.     CrossRef
  • The Key Role of Nutritional Intervention in Delaying Disease Progression and the Therapeutic Management of Diabetic Kidney Disease—A Challenge for Physicians and Patients
    Ileana Peride, Miruna Anastasiu, Silvia Alexandra Serban, Mirela Tiglis, Razvan Ene, Ana-Maria Nechita, Tiberiu Paul Neagu, Ionel Alexandru Checherita, Andrei Niculae
    Journal of Personalized Medicine.2024; 14(8): 778.     CrossRef
  • Efficacy and Safety of Pioglitazone Add-on in Patients with Type 2 Diabetes Mellitus Inadequately Controlled with Metformin and Dapagliflozin: A Multicenter, Randomized, Double-blind, and Placebo-controlled Study
    Yun Kyung Cho, Kyung-Soo Kim, Byung-Wan Lee, Jun Hwa Hong, Jae Myung Yu, Soo Lim, Ye An Kim, Chang Beom Lee, Sang Soo Kim, Soo Heon Kwak, Woo Je Lee
    Clinical Therapeutics.2024; 46(9): 662.     CrossRef
  • Islet transplantation in Korea
    Joonyub Lee, Kun‐Ho Yoon
    Journal of Diabetes Investigation.2024; 15(9): 1165.     CrossRef
  • Effect of gout and diabetic kidney disease on renal cancer development in Korea
    Seung Min Chung, Inha Jung, Da Young Lee, So Young Park, Ji Hee Yu, Jun Sung Moon, Ji A Seo, Kyungdo Han, Nan Hee Kim
    Clinical Kidney Journal.2024;[Epub]     CrossRef
  • Cardiovascular autonomic neuropathy and the risk of diabetic kidney disease
    Injeong Cho, Seohyun Lim, Minjae Kwon, Seung Min Chung, Jun Sung Moon, Ji Sung Yoon, Kyu Chang Won
    Frontiers in Endocrinology.2024;[Epub]     CrossRef
  • Changes in serum uteroglobin level in type 2 diabetes mellitus patients
    Joung Youl Lim, Sang-Hyeon Ju, Ji Min Kim, Hyon-Seung Yi, Ju Hee Lee, Hyun Jin Kim, Bon Jeong Ku, Kyong Hye Joung
    Frontiers in Endocrinology.2024;[Epub]     CrossRef
  • Sodium-glucose cotransporter 2 inhibitors in cardiocerebrovascular disease
    Jin Joo Park
    Cardiovascular Prevention and Pharmacotherapy.2024; 6(4): 103.     CrossRef
  • Systematic review of guideline recommendations for older and frail adults with type 2 diabetes mellitus
    Jennifer Bolt, Valeria Carvalho, Kristine Lin, Sung Ju Lee, Colleen Inglis
    Age and Ageing.2024;[Epub]     CrossRef
  • Socioeconomic inequalities in the prevalence, non-awareness, non-treatment, and non-control of diabetes among South Korean adults in 2021
    Seongju Kim, Dong Jun Kim, Hooyeon Lee, Dong Keon Yon
    PLOS ONE.2024; 19(11): e0313988.     CrossRef
  • Association of Uterine Leiomyoma with Type 2 Diabetes Mellitus in Young Women: A Population-Based Cohort Study
    Ji-Hee Sung, Kyung-Soo Kim, Kyungdo Han, Cheol-Young Park
    Diabetes & Metabolism Journal.2024; 48(6): 1105.     CrossRef
  • Combined impact of prediabetes and hepatic steatosis on cardiometabolic outcomes in young adults
    Wonsuk Choi, Minae Park, Sojeong Park, Ji Yong Park, A Ram Hong, Jee Hee Yoon, Kyoung Hwa Ha, Dae Jung Kim, Hee Kyung Kim, Ho-Cheol Kang
    Cardiovascular Diabetology.2024;[Epub]     CrossRef
  • Diagnosis and treatment of gestational diabetes mellitus
    Hyun Sun Ko, Yoon-Hee Choi
    Journal of the Korean Medical Association.2024; 67(11): 686.     CrossRef
  • Recent Advances in the Treatment of Diabetes in the Elderly
    Ha-Kyoung Park, Hun-Sung Kim
    Korean Journal of Geriatrics & Gerontology.2024; 25(3): 129.     CrossRef
  • Clinical Impact of Personalized Physician Education and Remote Feedback via a Digital Platform on Glycemic Control in Diabetes : A Pilot Randomized Controlled Trial (Preprint)
    Jin Yu, Jae-Hyoung Cho, Joonyub Lee, Yeoree Yang, Eun Young Lee, Seung-Hwan Lee
    JMIR mHealth and uHealth.2024;[Epub]     CrossRef
  • Management of Dyslipidemia in Patients with Diabetes Mellitus
    Kyung Ae Lee
    The Journal of Korean Diabetes.2023; 24(3): 111.     CrossRef
  • 2023 Clinical Practice Guidelines for Diabetes: Recommendations for Pharmacological Treatment of Type 2 Diabetes
    Junghyun Noh
    The Journal of Korean Diabetes.2023; 24(3): 127.     CrossRef
  • 2023 Clinical Practice Guidelines for Diabetes
    Min Kyong Moon
    The Journal of Korean Diabetes.2023; 24(3): 120.     CrossRef
  • 2023 Clinical Practice Guidelines for Diabetes: Management of Cardiovascular Risk Factors
    Ye Seul Yang
    The Journal of Korean Diabetes.2023; 24(3): 135.     CrossRef
  • A 33-Year-Old Man Presented with Abdominal Pain and Vomiting Starting a Day Ago
    Jong Han Choi
    The Korean Journal of Medicine.2023; 98(6): 289.     CrossRef
  • Comorbidity Patterns and Management in Inpatients with Endocrine Diseases by Age Groups in South Korea: Nationwide Data
    Sung-Soo Kim, Hun-Sung Kim
    Journal of Personalized Medicine.2023; 14(1): 42.     CrossRef
Basic Research
Article image
Adipose Tissue and Metabolic Health
Sung-Min An, Seung-Hee Cho, John C. Yoon
Diabetes Metab J. 2023;47(5):595-611.   Published online July 24, 2023
DOI: https://doi.org/10.4093/dmj.2023.0011
  • 18,095 View
  • 1,053 Download
  • 42 Web of Science
  • 45 Crossref
AbstractAbstract PDFPubReader   ePub   
In this review, we provide a brief synopsis of the connections between adipose tissue and metabolic health and highlight some recent developments in understanding and exploiting adipocyte biology. Adipose tissue plays critical roles in the regulation of systemic glucose and lipid metabolism and secretes bioactive molecules possessing endocrine, paracrine, and autocrine functions. Dysfunctional adipose tissue has a detrimental impact on metabolic health and is intimately involved in key aspects of metabolic diseases such as insulin resistance, lipid overload, inflammation, and organelle stress. Differences in the distribution of fat depots and adipose characteristics relate to divergent degrees of metabolic dysfunction found in metabolically healthy and unhealthy obese individuals. Thermogenic adipocytes increase energy expenditure via mitochondrial uncoupling or adenosine triphosphate-consuming futile substrate cycles, while functioning as a metabolic sink and participating in crosstalk with other metabolic organs. Manipulation of adipose tissue provides a wealth of opportunities to intervene and combat the progression of associated metabolic diseases. We discuss current treatment modalities for obesity including incretin hormone analogs and touch upon emerging strategies with therapeutic potential including exosome-based therapy, pharmacological activation of brown and beige adipocyte thermogenesis, and administration or inhibition of adipocyte-derived factors.

Citations

Citations to this article as recorded by  
  • VEGFB promotes adipose tissue thermogenesis by inhibiting norepinephrine clearance in macrophages
    Lei Wang, Jing Jin, Nuo Zhang, Yan Dai, Xueya Bai, Jinhao Li, Yueqi Yu, Xiaoling Shi, Hui Bai, Qing Yang, Bin Jiang, Jingjing Ben, Hanwen Zhang, Xiaoyu Li, Qi Chen, Xudong Zhu
    Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease.2025; 1871(1): 167536.     CrossRef
  • Predictors for Irreversibility of Contrast-Induced Acute Kidney Injury in Patients with Obesity After Contrast-Enhanced Computed Tomography Coronary Angiography
    Tetiana A. Berezina, Oleksandr O. Berezin, Michael Lichtenauer, Alexander E. Berezin
    Advances in Therapy.2025; 42(1): 293.     CrossRef
  • Effect of life course body composition on lipids and coronary atherosclerosis mediated by inflammatory biomarkers
    Liwan Fu, Hong Cheng, Jingfan Xiong, Pei Xiao, Xinying Shan, Yanyan Li, Yan Li, Xiaoyuan Zhao, Jie Mi
    Free Radical Biology and Medicine.2025; 227: 157.     CrossRef
  • Single-Cell Landscape and a Macrophage Subset Enhancing Brown Adipocyte Function in Diabetes (Diabetes Metab J 2024;48:885-900)
    Yea Eun Kang, Ju Hee Lee
    Diabetes & Metabolism Journal.2025; 49(1): 160.     CrossRef
  • The association of activity patterns on female reproductive diseases: a prospective cohort study of UK biobank
    Huanyu Guo, Yingzi Sun, Wei Gao, Yuqing Liu, Tianshu Han, Dandan Zhang
    BMC Public Health.2025;[Epub]     CrossRef
  • The association of visceral and subcutaneous fat areas with phenotypic age in non-elderly adults, mediated by HOMA-IR and HDL-C
    Yuanhong Liu, Min Xu, Liqing Wang, Linyun Meng, Mengran Li, Shumin Mu
    Lipids in Health and Disease.2025;[Epub]     CrossRef
  • Optimised Skeletal Muscle Mass as a Key Strategy for Obesity Management
    Thomas M. Barber, Stefan Kabisch, Andreas F. H. Pfeiffer, Martin O. Weickert
    Metabolites.2025; 15(2): 85.     CrossRef
  • Crosstalk Between Antioxidants and Adipogenesis: Mechanistic Pathways and Their Roles in Metabolic Health
    Minghao Fu, Kyung-Sik Yoon, Joohun Ha, Insug Kang, Wonchae Choe
    Antioxidants.2025; 14(2): 203.     CrossRef
  • Vitamin D and Type 2 Diabetes Mellitus: Molecular Mechanisms and Clinical Implications—A Narrative Review
    Héctor Fuentes-Barría, Raúl Aguilera-Eguía, Cherie Flores-Fernández, Lissé Angarita-Davila, Diana Rojas-Gómez, Miguel Alarcón-Rivera, Olga López-Soto, Juan Maureira-Sánchez
    International Journal of Molecular Sciences.2025; 26(5): 2153.     CrossRef
  • Fasting Mimicking Diet for Metabolic Syndrome: A Narrative Review of Human Studies
    Alina Delia Popa, Andreea Gherasim, Laura Mihalache, Lidia Iuliana Arhire, Mariana Graur, Otilia Niță
    Metabolites.2025; 15(3): 150.     CrossRef
  • SDCCAG3 inhibits adipocyte hypertrophy and improves obesity-related metabolic disorders via SDCCAG3/SMURF1/PPARγ axis
    Fenglei Huo, Chenghang Liu, Xi Wang, Jinzheng Li, Zhifeng Wang, Duanqin Liu, Weipeng Lan, Xingyan Zhu, Jing Lan
    Journal of Lipid Research.2025; 66(4): 100772.     CrossRef
  • Potential Therapeutic Exploitation of G Protein-Coupled Receptor 120 (GPR120/FFAR4) Signaling in Obesity-Related Metabolic Disorders
    Dariusz Szukiewicz
    International Journal of Molecular Sciences.2025; 26(6): 2501.     CrossRef
  • Renshen Zhuye decoction ameliorates high-fat diet-induced obesity and insulin resistance by modulating gut microbiota and metabolic homeostasis
    Fei Luo, Jie Yang, Zhiping Song, Yuan Zhao, Panpan Wang, Kaiyuan Liu, Xin Mou, Wenhong Liu, Wei Li
    Phytomedicine.2025; 141: 156655.     CrossRef
  • Inverse agonism of the FFA4 free fatty acid receptor controls both adipogenesis and mature adipocyte function
    W.S. Alshammari, E.M. Duncan, L. Vita, M. Kenawy, B. Dibnah, M. Wabitsch, G.W. Gould, B.D. Hudson
    Cellular Signalling.2025; 131: 111714.     CrossRef
  • Decoding metabolic connections: the role of salivary amylase activity in modulating visceral fat and triglyceride glucose index
    Gita Erta, Gita Gersone, Antra Jurka, Peteris Tretjakovs
    Lipids in Health and Disease.2025;[Epub]     CrossRef
  • Research Progress on the Relationship between Visceral Obesity and Related Indices and Type 2 Diabetes Mellitus
    娅娟 谭
    Journal of Clinical Personalized Medicine.2025; 04(02): 175.     CrossRef
  • Genetically determined fatty liver disease and type 2 diabetes mellitus in db/db mice. The effect of melatonin on lipid metabolism in the liver, micro- and ultrastructural characteristics
    S. V. Michurina, S. I. Kolesnikov, D. V. Vasendin, I. Yu. Ishchenko
    Acta Biomedica Scientifica.2025; 10(1): 238.     CrossRef
  • Different solubility dietary fibers regulate thermogenesis in rats through modulating adipose tissue activity and colonic Clostridiales
    Zirou Yu, Chunjie Hou, Chenyu Shi, Ya Huang, Hu Liu, Fenglai Wang
    Food Bioscience.2025; 68: 106468.     CrossRef
  • New Perspectives on the Molecular Action of Metformin in the Context of Cellular Transduction and Adipogenesis
    Jorge Enrique González-Casanova, Mario Navarro-Marquez, Tamara Saez-Tamayo, Lissé Angarita, Samuel Durán-Agüero, Héctor Fuentes-Barría, Valmore Bermúdez, Diana Marcela Rojas-Gómez
    International Journal of Molecular Sciences.2025; 26(8): 3690.     CrossRef
  • Pharmacological targets at the lysosomal autophagy–NLRP3 inflammasome crossroads
    Srinivasa Reddy Bonam, Dylan Mastrippolito, Philippe Georgel, Sylviane Muller
    Trends in Pharmacological Sciences.2024; 45(1): 81.     CrossRef
  • Senescent adipocytes and type 2 diabetes – current knowledge and perspective concepts
    Weronika Kruczkowska, Julia Gałęziewska, Mateusz Kciuk, Adrianna Gielecińska, Elżbieta Płuciennik, Zbigniew Pasieka, Lin-Yong Zhao, Yi-Jin Yu, Damian Kołat, Żaneta Kałuzińska-Kołat
    Biomolecular Concepts.2024;[Epub]     CrossRef
  • Visceral Adipose Tissue: The Hidden Culprit for Type 2 Diabetes
    Sneha Dhokte, Krzysztof Czaja
    Nutrients.2024; 16(7): 1015.     CrossRef
  • Beyond the Cold: Activating Brown Adipose Tissue as an Approach to Combat Obesity
    Cristina Elena Negroiu, Iulia Tudorașcu, Cristina Maria Bezna, Sanziana Godeanu, Marina Diaconu, Raluca Danoiu, Suzana Danoiu
    Journal of Clinical Medicine.2024; 13(7): 1973.     CrossRef
  • Differential Modulation by Eicosapentaenoic Acid (EPA) and Docosahexaenoic Acid (DHA) of Mesenteric Fat and Macrophages and T Cells in Adipose Tissue of Obese fa/fa Zucker Rats
    Lena Hong, Peter Zahradka, Carla G. Taylor
    Nutrients.2024; 16(9): 1311.     CrossRef
  • Omics Insights into Epicardial Adipose Tissue: Unravelling Its Molecular Landscape
    Ivona Mitu, Roxana Popescu, Cristina-Daniela Dimitriu, Radu-Ștefan Miftode, Irina-Iuliana Costache, Ovidiu Mitu
    Applied Sciences.2024; 14(10): 4173.     CrossRef
  • White-to-Beige and Back: Adipocyte Conversion and Transcriptional Reprogramming
    Stanislav Boychenko, Vera S. Egorova, Andrew Brovin, Alexander D. Egorov
    Pharmaceuticals.2024; 17(6): 790.     CrossRef
  • Obesity and Obesity-Related Disorders—Editorial
    Grażyna Nowicka
    International Journal of Molecular Sciences.2024; 25(14): 7954.     CrossRef
  • Protein Arginine Methyltransferases: Emerging Targets in Cardiovascular and Metabolic Disease
    Yan Zhang, Shibo Wei, Eun-Ju Jin, Yunju Jo, Chang-Myung Oh, Gyu-Un Bae, Jong-Sun Kang, Dongryeol Ryu
    Diabetes & Metabolism Journal.2024; 48(4): 487.     CrossRef
  • Butyric acid reduced lipid deposition in immortalized chicken preadipocyte by inhibiting cell proliferation and differentiation
    Xiaoying Liu, Kailong Qin, Chaohui Wang, Xi Sun, Yun Li, Yanli Liu, Xiaojun Yang
    Poultry Science.2024; 103(11): 104171.     CrossRef
  • Regulatory effect of β-glucan secreted by Rhizobium pusense on triglyceride metabolism and their relationships with the modulation of intestinal microbiota in mice fed a high-fat diet
    Bin Zhang, Wei Zhao, Dong Song, Xiaomei Lyu
    Food & Function.2024; 15(17): 8759.     CrossRef
  • Impact of a 12-Week Dietary Intervention on Adipose Tissue Metabolic Markers in Overweight Women of Reproductive Age
    Gita Erta, Gita Gersone, Antra Jurka, Peteris Tretjakovs
    International Journal of Molecular Sciences.2024; 25(15): 8512.     CrossRef
  • Cholesterol Efflux Decreases TLR4-Target Gene Expression in Cultured Macrophages Exposed to T. brucei Ghosts
    Lawrence Fernando, Jing Echesabal-Chen, Murphy Miller, Rhonda Reigers Powell, Terri Bruce, Apurba Paul, Nava Poudyal, Joshua Saliutama, Kristina Parman, Kimberly S. Paul, Alexis Stamatikos
    Microorganisms.2024; 12(8): 1730.     CrossRef
  • Translational potential of mesenchymal stem cells in regenerative therapies for human diseases: challenges and opportunities
    Song Zhidu, Tao Ying, Jiang Rui, Zhang Chao
    Stem Cell Research & Therapy.2024;[Epub]     CrossRef
  • Assessment of energy balance in nutritional counseling – fact or myth?
    Mirosław Kiedrowski
    Postępy Higieny i Medycyny Doświadczalnej.2024; 78(1): 82.     CrossRef
  • Inferring the metabolic rate of bone
    Chen Hou, Timothy G. Bromage
    Comparative Biochemistry and Physiology Part A: Molecular & Integrative Physiology.2024; 298: 111748.     CrossRef
  • Research progress on application of dental stem cells in alveolar bone and periodontal regeneration
    Zhaoyong Liu, Chengbin Guo, Jing Guo, Shan Huang, Peng Du
    MedComm – Future Medicine.2024;[Epub]     CrossRef
  • Anti-Obesity Effect of Fresh and Browned Magnolia denudata Flowers in 3T3-L1 Adipocytes
    Deok Jae Lee, Jae Ho Yeom, Yong Kwon Lee, Yong Hoon Joo, Namhyun Chung
    Applied Sciences.2024; 14(20): 9254.     CrossRef
  • Autophagy Alterations in White and Brown Adipose Tissues of Mice Exercised under Different Training Protocols
    Isaac Tamargo-Gómez, Manuel Fernández-Sanjurjo, Helena Codina-Martínez, Cristina Tomás-Zapico, Eduardo Iglesias-Gutiérrez, Benjamín Fernández-García, Álvaro F. Fernández
    Frontiers in Bioscience-Landmark.2024;[Epub]     CrossRef
  • Stimulation of non-shivering thermogenesis by bioactive compounds: A focus on gut microbiota-mediated mechanisms
    Yasmin Alhamoud, Tuerxunayi Abudumijiti, Junhao Wu, Lu Lu, Minjie Zhao, Xiaohu Luo, Fengqin Feng, Jing Wang
    Trends in Food Science & Technology.2024; 154: 104779.     CrossRef
  • Coexisting metabolic dysfunction-associated steatotic liver disease exacerbates in-hospital outcomes in patients with heat stroke
    Ping Zhang, Guo Tang, Hongguang Gao, Tianshan Zhang, Sha Yang, Tao Cheng, Rong Yao
    Frontiers in Medicine.2024;[Epub]     CrossRef
  • Body Roundness Index Trajectories and the Risk of Cancer: A Cohort Study
    Yue Chen, Yiming Wang, Xin Zheng, Tong Liu, Chenan Liu, Shiqi Lin, Hailun Xie, Jinyu Shi, Xiaoyue Liu, Xiangming Ma, Li Deng, Shouling Wu, Hanping Shi
    Cancer Medicine.2024;[Epub]     CrossRef
  • Identification of Adipsin as a Biomarker of Beta Cell Function in Patients with Type 2 Diabetes
    Jae-Hyung Park, Thi Nhi Nguyen, Hye Min Shim, Gyeong Im Yu, Eun Yeong Ha, Hochan Cho
    Journal of Clinical Medicine.2024; 13(23): 7351.     CrossRef
  • Cathelicidin: Insights into Its Impact on Metabolic Syndrome and Chronic Inflammation
    Alina Delia Popa, Andreea Gherasim, Lavinia Caba, Otilia Niță, Mariana Graur, Laura Mihalache, Lidia Iuliana Arhire
    Metabolites.2024; 14(12): 672.     CrossRef
  • From Adipose to Ailing Kidneys: The Role of Lipid Metabolism in Obesity-Related Chronic Kidney Disease
    Wenchao Xu, Yuting Zhu, Siyuan Wang, Jihong Liu, Hao Li
    Antioxidants.2024; 13(12): 1540.     CrossRef
  • Spotlight on the Mechanism of Action of Semaglutide
    Ilias Papakonstantinou, Konstantinos Tsioufis, Vasiliki Katsi
    Current Issues in Molecular Biology.2024; 46(12): 14514.     CrossRef
Technology/Device
Article image
Advances in Continuous Glucose Monitoring and Integrated Devices for Management of Diabetes with Insulin-Based Therapy: Improvement in Glycemic Control
Jee Hee Yoo, Jae Hyeon Kim
Diabetes Metab J. 2023;47(1):27-41.   Published online January 12, 2023
DOI: https://doi.org/10.4093/dmj.2022.0271
  • 15,248 View
  • 603 Download
  • 28 Web of Science
  • 36 Crossref
AbstractAbstract PDFPubReader   ePub   
Continuous glucose monitoring (CGM) technology has evolved over the past decade with the integration of various devices including insulin pumps, connected insulin pens (CIPs), automated insulin delivery (AID) systems, and virtual platforms. CGM has shown consistent benefits in glycemic outcomes in type 1 diabetes mellitus (T1DM) and type 2 diabetes mellitus (T2DM) treated with insulin. Moreover, the combined effect of CGM and education have been shown to improve glycemic outcomes more than CGM alone. Now a CIP is the expected future technology that does not need to be worn all day like insulin pumps and helps to calculate insulin doses with a built-in bolus calculator. Although only a few clinical trials have assessed the effectiveness of CIPs, they consistently show benefits in glycemic outcomes by reducing missed doses of insulin and improving problematic adherence. AID systems and virtual platforms made it possible to achieve target glycosylated hemoglobin in diabetes while minimizing hypoglycemia, which has always been challenging in T1DM. Now fully automatic AID systems and tools for diabetes decisions based on artificial intelligence are in development. These advances in technology could reduce the burden associated with insulin treatment for diabetes.

Citations

Citations to this article as recorded by  
  • Inter-temporal dynamic joint learning model considering intra- and inter-day mutable correlations for blood glucose level prediction
    Shuang Wen, Hongru Li, Yinghua Yang
    Biomedical Signal Processing and Control.2025; 101: 107204.     CrossRef
  • Glycemia Risk Index is Associated With Risk of Albuminuria Among Individuals With Type 1 Diabetes
    Ji Yoon Kim, Jee Hee Yoo, Nam Hoon Kim, Jae Hyeon Kim
    Journal of Diabetes Science and Technology.2025;[Epub]     CrossRef
  • Real-World Life Analysis of a Continuous Glucose Monitoring and Smart Insulin Pen System in Type 1 Diabetes: A Cohort Study
    Paola Pantanetti, Giovanni Cangelosi, Sara Morales Palomares, Gaetano Ferrara, Federico Biondini, Stefano Mancin, Gabriele Caggianelli, Mauro Parozzi, Marco Sguanci, Fabio Petrelli
    Diabetology.2025; 6(1): 7.     CrossRef
  • Abuse-deterrent wearable device with potential for extended delivery of opioid drugs
    Myoung Ju Kim, Jae Min Park, Jun Su Lee, Ji Yang Lee, Juhui Lee, Chang Hee Min, Min Ji Kim, Jae Hoon Han, Eun Jung Kwon, Young Bin Choy
    Biomedical Engineering Letters.2025; 15(2): 427.     CrossRef
  • Unlocking Real-Time Data Access in Diabetes Management: Toward an Interoperability Model
    Pietro Randine, Miriam Kopperstad Wolff, Matthias Pocs, Ian R. O. Connell, Joseph A. Cafazzo, Eirik Årsand
    Journal of Diabetes Science and Technology.2025;[Epub]     CrossRef
  • Harnessing Machine Learning, a Subset of Artificial Intelligence, for Early Detection and Diagnosis of Type 1 Diabetes: A Systematic Review
    Rahul Mittal, Matthew B. Weiss, Alexa Rendon, Shirin Shafazand, Joana R N Lemos, Khemraj Hirani
    International Journal of Molecular Sciences.2025; 26(9): 3935.     CrossRef
  • The usefulness of continuous glucose monitoring in the diagnostic approach to hypoglycemia after metabolic surgery
    Diana Cristina Henao, Ana María Gómez, Sofía Robledo, Ricardo Rosero
    Mini-invasive Surgery.2025;[Epub]     CrossRef
  • Recent advances in artificial intelligence-assisted endocrinology and diabetes
    Ioannis T. Oikonomakos, Ranjit M. Anjana, Viswanathan Mohan, Charlotte Steenblock, Stefan R. Bornstein
    Exploration of Endocrine and Metabolic Disease.2024; 1(1): 16.     CrossRef
  • Accuracy and Safety of the 15-Day CareSens Air Continuous Glucose Monitoring System
    Kyung-Soo Kim, Seung-Hwan Lee, Won Sang Yoo, Cheol-Young Park
    Diabetes Technology & Therapeutics.2024; 26(4): 222.     CrossRef
  • Real-World Continuous Glucose Monitoring Data from a Population with Type 1 Diabetes in South Korea: Nationwide Single-System Analysis
    Ji Yoon Kim, Sang-Man Jin, Sarah B. Andrade, Boyang Chen, Jae Hyeon Kim
    Diabetes Technology & Therapeutics.2024; 26(6): 394.     CrossRef
  • Recent advances in the precision control strategy of artificial pancreas
    Wuyi Ming, Xudong Guo, Guojun Zhang, Yinxia Liu, Yongxin Wang, Hongmei Zhang, Haofang Liang, Yuan Yang
    Medical & Biological Engineering & Computing.2024; 62(6): 1615.     CrossRef
  • Digital Health in Diabetes and Cardiovascular Disease
    Dorothy Avoke, Abdallah Elshafeey, Robert Weinstein, Chang H. Kim, Seth S. Martin
    Endocrine Research.2024; 49(3): 124.     CrossRef
  • Continuous glucose monitoring with structured education in adults with type 2 diabetes managed by multiple daily insulin injections: a multicentre randomised controlled trial
    Ji Yoon Kim, Sang-Man Jin, Kang Hee Sim, Bo-Yeon Kim, Jae Hyoung Cho, Jun Sung Moon, Soo Lim, Eun Seok Kang, Cheol-Young Park, Sin Gon Kim, Jae Hyeon Kim
    Diabetologia.2024; 67(7): 1223.     CrossRef
  • Smart solutions in hypertension diagnosis and management: a deep dive into artificial intelligence and modern wearables for blood pressure monitoring
    Anubhuti Juyal, Shradha Bisht, Mamta F. Singh
    Blood Pressure Monitoring.2024; 29(5): 260.     CrossRef
  • Emerging trends in functional molecularly imprinted polymers for electrochemical detection of biomarkers
    Sanjida Yeasmin, Li-Jing Cheng
    Biomicrofluidics.2024;[Epub]     CrossRef
  • Continuous glucose monitoring in pregnant women with pregestational type 2 diabetes: a narrative review
    Sylvia Ye, Ibrahim Shahid, Christopher J Yates, Dev Kevat, I-Lynn Lee
    Obstetric Medicine.2024; 17(4): 194.     CrossRef
  • Advancements in nanohybrid material-based acetone gas sensors relevant to diabetes diagnosis: A comprehensive review
    Arpit Verma, Deepankar Yadav, Subramanian Natesan, Monu Gupta, Bal Chandra Yadav, Yogendra Kumar Mishra
    Microchemical Journal.2024; 201: 110713.     CrossRef
  • Current treatment options of diabetes mellitus type 1 in pediatric population
    Petr Polák, Renata Pomahačová, Karel Fiklík, Petra Paterová, Josef Sýkora
    Pediatrie pro praxi.2024; 25(3): 161.     CrossRef
  • Efectividad de un sistema híbrido de circuito cerrado en pacientes con diabetes tipo 1 durante el ejercicio físico: un estudio descriptivo en la vida real
    Ruben Martin-Payo, Maria del Mar Fernandez-Alvarez, Rebeca García-García, Ángela Pérez-Varela, Shelini Surendran, Isolina Riaño-Galán
    Anales de Pediatría.2024; 101(3): 183.     CrossRef
  • Effectiveness of a hybrid closed-loop system for children and adolescents with type 1 diabetes during physical exercise: A cross-sectional study in real life
    Ruben Martin-Payo, Maria del Mar Fernandez-Alvarez, Rebeca García-García, Ángela Pérez-Varela, Shelini Surendran, Isolina Riaño-Galán
    Anales de Pediatría (English Edition).2024; 101(3): 183.     CrossRef
  • Real-time continuous glucose monitoring vs. self-monitoring of blood glucose: cost-utility in South Korean type 2 diabetes patients on intensive insulin
    Ji Yoon Kim, Sabrina Ilham, Hamza Alshannaq, Richard F. Pollock, Waqas Ahmed, Gregory J. Norman, Sang-Man Jin, Jae Hyeon Kim
    Journal of Medical Economics.2024; 27(1): 1245.     CrossRef
  • Impact of missed insulin doses on glycaemic parameters in people with diabetes using smart insulin pens
    Malavika Varma, David J T Campbell
    Evidence Based Nursing.2024; : ebnurs-2024-104109.     CrossRef
  • Clinical Trial Protocol for Porcine Islet Xenotransplantation in South Korea
    Byung-Joon Kim, Jun-Seop Shin, Byoung-Hoon Min, Jong-Min Kim, Chung-Gyu Park, Hee-Jung Kang, Eung Soo Hwang, Won-Woo Lee, Jung-Sik Kim, Hyun Je Kim, Iov Kwon, Jae Sung Kim, Geun Soo Kim, Joonho Moon, Du Yeon Shin, Bumrae Cho, Heung-Mo Yang, Sung Joo Kim,
    Diabetes & Metabolism Journal.2024; 48(6): 1160.     CrossRef
  • Long-Term Benefits of Continuous Glucose Monitoring Combined with Insulin Pump Therapy
    Rukhsana Zulfiqar, Komal Abbas, Saeeda Khan, Kanwal Fatima, Adnan Manzoor, Muhammad Awais
    Indus Journal of Bioscience Research.2024; 2(2): 785.     CrossRef
  • Continuous Glucose Monitoring—New Diagnostic Tool in Complex Pathophysiological Disorder of Glucose Metabolism in Children and Adolescents with Obesity
    Marko Simunovic, Marko Kumric, Doris Rusic, Martina Paradzik Simunovic, Josko Bozic
    Diagnostics.2024; 14(24): 2801.     CrossRef
  • Innovations in Diabetes Management for Pregnant Women: Artificial Intelligence and the Internet of Medical Things
    Ellen M. Murrin, Antonio F. Saad, Scott Sullivan, Yuri Millo, Menachem Miodovnik
    American Journal of Perinatology.2024;[Epub]     CrossRef
  • Glycemic Outcomes During Early Use of the MiniMed™ 780G Advanced Hybrid Closed-Loop System with Guardian™ 4 Sensor
    Toni L. Cordero, Zheng Dai, Arcelia Arrieta, Fang Niu, Melissa Vella, John Shin, Andrew S. Rhinehart, Jennifer McVean, Scott W. Lee, Robert H. Slover, Gregory P. Forlenza, Dorothy I. Shulman, Rodica Pop-Busui, James R. Thrasher, Mark S. Kipnes, Mark P. Ch
    Diabetes Technology & Therapeutics.2023; 25(9): 652.     CrossRef
  • Navigating the Seas of Glycemic Control: The Role of Continuous Glucose Monitoring in Type 1 Diabetes Mellitus
    Jun Sung Moon
    Diabetes & Metabolism Journal.2023; 47(3): 345.     CrossRef
  • APSec1.0: Innovative Security Protocol Design with Formal Security Analysis for the Artificial Pancreas System
    Jiyoon Kim, Jongmin Oh, Daehyeon Son, Hoseok Kwon, Philip Virgil Astillo, Ilsun You
    Sensors.2023; 23(12): 5501.     CrossRef
  • Advances and Development of Electronic Neural Interfaces
    Xue Jiaxiang, Liu Zhixin
    Journal of Computing and Natural Science.2023; : 147.     CrossRef
  • Continuous Glucose Monitoring (CGM) and Metabolic Control in a Cohort of Patients with Type 1 Diabetes and Coeliac Disease
    Flavia Amaro, Maria Alessandra Saltarelli, Marina Primavera, Marina Cerruto, Stefano Tumini
    Endocrines.2023; 4(3): 595.     CrossRef
  • Comparison of Glycemia Risk Index with Time in Range for Assessing Glycemic Quality
    Ji Yoon Kim, Jee Hee Yoo, Jae Hyeon Kim
    Diabetes Technology & Therapeutics.2023; 25(12): 883.     CrossRef
  • The Benefits Of Continuous Glucose Monitoring In Pregnancy
    Jee Hee Yoo, Jae Hyeon Kim
    Endocrinology and Metabolism.2023; 38(5): 472.     CrossRef
  • The Growing Challenge of Diabetes Management in an Aging Society
    Seung-Hwan Lee
    Diabetes & Metabolism Journal.2023; 47(5): 630.     CrossRef
  • An Observational Pilot Study of a Tailored Environmental Monitoring and Alert System for Improved Management of Chronic Respiratory Diseases
    Mohammed Alotaibi, Fady Alnajjar, Badr A Alsayed, Tareq Alhmiedat, Ashraf M Marei, Anas Bushnag, Luqman Ali
    Journal of Multidisciplinary Healthcare.2023; Volume 16: 3799.     CrossRef
  • Smart Insulin Pen: Managing Insulin Therapy for People with Diabetes in the Digital Era
    Jee Hee Yoo, Jae Hyeon Kim
    The Journal of Korean Diabetes.2023; 24(4): 190.     CrossRef
Metabolic Risk/Epidemiology
Article image
Gestational Diabetes Mellitus and Its Implications across the Life Span
Brandy Wicklow, Ravi Retnakaran
Diabetes Metab J. 2023;47(3):333-344.   Published online February 8, 2023
DOI: https://doi.org/10.4093/dmj.2022.0348
  • 18,094 View
  • 1,026 Download
  • 28 Web of Science
  • 32 Crossref
AbstractAbstract PDFPubReader   ePub   
Gestational diabetes mellitus (GDM) has historically been perceived as a medical complication of pregnancy that also serves as a harbinger of maternal risk of developing type 2 diabetes mellitus (T2DM) in the future. In recent decades, a growing body of evidence has detailed additional lifelong implications that extend beyond T2DM, including an elevated risk of ultimately developing cardiovascular disease. Furthermore, the risk factors that mediate this lifetime cardiovascular risk are evident not only after delivery but are present even before the pregnancy in which GDM is first diagnosed. The concept thus emerging from these data is that the diagnosis of GDM enables the identification of women who are already on an enhanced track of cardiometabolic risk that starts early in life. Studies of the offspring of pregnancies complicated by diabetes now suggest that the earliest underpinnings of this cardiometabolic risk profile may be determined in utero and may first manifest clinically in childhood. Accordingly, from this perspective, GDM is now seen as a chronic metabolic disorder that holds implications across the life span of both mother and child.

Citations

Citations to this article as recorded by  
  • The Value of lncRNAs as a Biomarker for the Diagnosis of Gestational Diabetes: A Meta-Analysis
    Yang Fan, Xin Chen, Song Yang, Hongxia Tu, Youyi Zhang, Mingyi Wang, Jingying Jiang
    Hormone and Metabolic Research.2025; 57(01): 67.     CrossRef
  • Evidence-Based Care Practices for Children Exposed to a Diabetes-Complicated Pregnancy
    Valerie C. Martinez, Jacqueline B. LaManna, Susan B. Quelly, Suzanne Hyer, Jean W. Davis, Carmen Giurgescu
    The Journal for Nurse Practitioners.2025; 21(1): 105254.     CrossRef
  • Genetic and epigenetic alterations associated with gestational diabetes mellitus and adverse neonatal outcomes
    Amreen Shamsad, Tanu Gautam, Renu Singh, Monisha Banerjee
    World Journal of Clinical Pediatrics.2025;[Epub]     CrossRef
  • Untreated women with first trimester fasting glycaemia 92−125 mg/dL and risk of gestational diabetes mellitus in the 24−28th week OGTT: prevalence and predictors
    Catarina Cidade-Rodrigues, Bruna Silva, Vânia Benido Silva, Catarina Chaves, Maria Luís Mazeda, Alexandra Araújo, Cláudia Machado, Catarina A. Pereira, Vânia Gomes, Odete Figueiredo, Anabela Melo, Anabela Ferreira, Mariana Martinho, Ana Morgado, Ana Saave
    Acta Diabetologica.2025;[Epub]     CrossRef
  • A Review of the Impact of Gestational Diabetes on Fetal Brain Development: An Update on Neurosonographic Markers During the Last Decade
    Efthymios Oikonomou, Christos Chatzakis, Sofoklis Stavros, Anastasios Potiris, Konstantinos Nikolettos, Sotirios Sotiriou, Ekaterini Domali, Nikolaos Nikolettos, Alexandros Sotiriadis, Angeliki Gerede
    Life.2025; 15(2): 210.     CrossRef
  • Gestational Diabetes Mellitus: Mechanisms Underlying Maternal and Fetal Complications
    Jooyeop Lee, Na Keum Lee, Joon Ho Moon
    Endocrinology and Metabolism.2025; 40(1): 10.     CrossRef
  • Unveiling Gestational Diabetes: An Overview of Pathophysiology and Management
    Rahul Mittal, Karan Prasad, Joana R. N. Lemos, Giuliana Arevalo, Khemraj Hirani
    International Journal of Molecular Sciences.2025; 26(5): 2320.     CrossRef
  • In-patient expenditure between 2011 and 2021 for patients with type 2 diabetes mellitus: a hospital-based multicenter retrospective study in southwest China
    Yuxin He, Juntao Tan, Qingzhu Tan, Xiao Zhang, Yunyu Liu, Yang Tang
    Frontiers in Public Health.2025;[Epub]     CrossRef
  • Knockdown of Aurora kinase B alleviates high glucose-triggered trophoblast cells damage and inflammation during gestational diabetes
    Yuzhuo Ma, Yongyun Shi, Yujie Liu
    Open Life Sciences.2025;[Epub]     CrossRef
  • Prediction of Gestational Diabetes Mellitus (GDM) risk in early pregnancy based on clinical data and ultrasound information: a nomogram
    Tong Zhu, Lin Tang, Man Qin, Wen-Wen Wang, Ling Chen
    BMC Medical Informatics and Decision Making.2025;[Epub]     CrossRef
  • Metabolomic profiling reveals early biomarkers of gestational diabetes mellitus and associated hepatic steatosis
    Youngae Jung, Seung Mi Lee, Jinhaeng Lee, Yeonjin Kim, Woojoo Lee, Ja Nam Koo, Ig Hwan Oh, Kue Hyun Kang, Byoung Jae Kim, Sun Min Kim, Jeesun Lee, Ji Hoi Kim, Yejin Bae, Sang Youn Kim, Gyoung Min Kim, Sae Kyung Joo, Dong Hyeon Lee, Joon Ho Moon, Bo Kyung
    Cardiovascular Diabetology.2025;[Epub]     CrossRef
  • Genetics and epigenetics in gestational diabetes contributing to type 2 diabetes
    Dewei Kong, Oliwia Kowalik, Emma Garratt, Keith M. Godfrey, Shiao-Yng Chan, Adrian Kee Keong Teo
    Trends in Endocrinology & Metabolism.2025;[Epub]     CrossRef
  • ATP5me alleviates high glucose-induced myocardial cell injury
    Qingsha Hou, Fang Yan, Xiuling Li, Huanling Liu, Xiang Yang, Xudong Dong
    International Immunopharmacology.2024; 129: 111626.     CrossRef
  • Prevalence and Predictors of Gestational Diabetes Mellitus and Overt Diabetes in Pregnancy: A Secondary Analysis of Nationwide Data from India
    Saurav Basu, Vansh Maheshwari, Rutul Gokalani, Chandrakant Lahariya
    Preventive Medicine: Research & Reviews.2024; 1(1): 52.     CrossRef
  • Serum betaine and dimethylglycine in mid-pregnancy and the risk of gestational diabetes mellitus: a case-control study
    Ziqing Zhou, Yao Yao, Yanan Sun, Xin Wang, Shang Huang, Jianli Hou, Lijun Wang, Fengxiang Wei
    Endocrine.2024; 85(2): 649.     CrossRef
  • Quality assessment of videos on social media platforms related to gestational diabetes mellitus in China: A cross-section study
    Qin-Yu Cai, Jing Tang, Si-Zhe Meng, Yi Sun, Xia Lan, Tai-Hang Liu
    Heliyon.2024; 10(7): e29020.     CrossRef
  • Association of VDR gene variant rs2228570-FokI with gestational diabetes mellitus susceptibility in Arab women
    Maysa Alzaim, Mohammed G.A. Ansari, Abeer A. Al-Masri, Malak N.K. Khattak, Abir Alamro, Amani Alghamdi, Amal Alenad, Majed Alokail, Omar S. Al-Attas, Ahmad G. Al-Zahrani, Nasser M. Al-Daghri
    Heliyon.2024; 10(11): e32048.     CrossRef
  • Variations in the LINGO2 and GLIS3 Genes and Gene–Environment Interactions Increase Gestational Diabetes Mellitus Risk in Chinese Women
    Xiao Huang, Weiwei Liang, Runqiu Yang, Lei Jin, Kai Zhao, Juan Chen, Xuejun Shang, Yuanzhong Zhou, Xin Wang, Hongsong Yu
    Environmental Science & Technology.2024; 58(26): 11596.     CrossRef
  • Pre-gestational diabetes mellitus, gestational diabetes mellitus, and its association with the MTHFR C677T polymorphism
    Nga Thi Ngoc Pham, Chau Thi Ngoc Huynh, Ai Thuy Thuy Nguyen, Chuong Quoc Ho, Linh My Duong, Dung The Bui, Ha Hong Nguyen
    Medicine.2024; 103(28): e38648.     CrossRef
  • Amelioration of Insulin Resistance after Delivery Is Associated with Reduced Risk of Postpartum Diabetes in Women with Gestational Diabetes Mellitus
    Heejun Son, Joon Ho Moon, Sung Hee Choi, Nam H. Cho, Soo Heon Kwak, Hak Chul Jang
    Endocrinology and Metabolism.2024; 39(5): 701.     CrossRef
  • Oral Wound Healing in Aging Population
    Claudia Florina Bogdan-Andreescu, Andreea-Mariana Bănățeanu, Oana Botoacă, Carmen Liliana Defta, Cristian-Viorel Poalelungi, Anca Daniela Brăila, Constantin Marian Damian, Matei Georgian Brăila, Laurențiu Mihai Dȋră
    Surgeries.2024; 5(4): 956.     CrossRef
  • Relationship between life’s essential 8 and the risk of gestational diabetes among us adults
    Lu Qin, Zhixing Fan, Qian Shi, Hao Hu, Fang Ma, Yanlin Huang, Fengzhi Tan
    The Journal of Maternal-Fetal & Neonatal Medicine.2024;[Epub]     CrossRef
  • The role of quercetin in NLRP3-associated inflammation
    Jiaqi Wu, Tongtong Lv, Yu Liu, Yifan Liu, Yukun Han, Xin Liu, Xiaochun Peng, Fengru Tang, Jun Cai
    Inflammopharmacology.2024; 32(6): 3585.     CrossRef
  • A Systematic Patent Review (2008-2023) for Treatment in Pregnancy
    Kélle Velasques Pereira, Camila Oliveira Pacheco, Izabel Almeida Alves, Sandra Elisa Haas
    Current Medicinal Chemistry.2024; 31(38): 6288.     CrossRef
  • Usefulness of Glycated Albumin Levels in Predicting the Maternal or Neonatal Complications of Gestational Diabetes Mellitus during Late Pregnancy in South Korea: A Retrospective Study
    Jihan Kim, Sami Lee, Jong Sung Kim
    Korean Journal of Family Medicine.2024;[Epub]     CrossRef
  • Clinical Significance of miR-339-5p in Early Diagnosis and Predicting Pregnancy Outcome of Chinese Patients with Liver Injury in Pregnancy
    Ying Wang, Lichao Yuan, Falong Hu, Huilan Yu, Qiaofang Yang, Xiujuan Zheng
    Clinical and Experimental Obstetrics & Gynecology.2024;[Epub]     CrossRef
  • Single and Joint Associations Between Blood Cell‐Based Inflammatory Indicator in Early Pregnancy and Risk of Gestational Diabetes Mellitus (GDM): A Prospective Cohort Study
    Yanling Xiao, Haonan Zhang, Songlin An, Rui Yu, Jing Yang, Xingting Zheng, Nian Wu, Lin Tao, Dengqing Liao, Mingyu Deng, Zhongmei Hu, Yijun Liu, Qing Chen, Yuanzhong Zhou
    American Journal of Reproductive Immunology.2024;[Epub]     CrossRef
  • Gestational diabetes-combined excess weight gain exacerbates gut microbiota dysbiosis in newborns, associated with reduced abundance of Clostridium, Coriobacteriaceae, and Collinsella
    Yunshan Xiao, Yuan Shi, Yan Ni, Meilan Ni, Yuxin Yang, Xueqin Zhang
    Frontiers in Cellular and Infection Microbiology.2024;[Epub]     CrossRef
  • Untargeted metabolomics profiling of gestational diabetes mellitus: insights into early diagnosis and metabolic pathway alterations
    Shereen M. Aleidi, Hiba Al Fahmawi, Reem H. AlMalki, Maha Al Mogren, Mohammad Alwahsh, Muhammad Mujammami, Michele Costanzo, Anas Abdel Rahman
    Frontiers in Molecular Biosciences.2024;[Epub]     CrossRef
  • Inflammation and decreased cardiovagal modulation are linked to stress and depression at 36th week of pregnancy in gestational diabetes mellitus
    Manoharan Renugasundari, Gopal Krushna Pal, Latha Chaturvedula, Nivedita Nanda, K. T. Harichandrakumar, Thiyagarajan Durgadevi
    Scientific Reports.2023;[Epub]     CrossRef
  • Women with gestational diabetes mellitus, controlled for plasma glucose level, exhibit maternal and fetal dyslipidaemia that may warrant treatment
    Barbara J. Meyer, Colin Cortie, Marloes Dekker-Nitert, Helen L. Barrett, Dilys J. Freeman
    Diabetes Research and Clinical Practice.2023; 204: 110929.     CrossRef
  • Pregnancy diet to prevent gestational diabetes: study design and dietary assessments
    Sylvia H. Ley
    The American Journal of Clinical Nutrition.2023; 118(5): 847.     CrossRef
Complications
Article image
Pharmacological and Nonpharmacological Treatments for Painful Diabetic Peripheral Neuropathy
Han Na Jang, Tae Jung Oh
Diabetes Metab J. 2023;47(6):743-756.   Published online September 6, 2023
DOI: https://doi.org/10.4093/dmj.2023.0018
  • 19,179 View
  • 1,148 Download
  • 24 Web of Science
  • 25 Crossref
AbstractAbstract PDFPubReader   ePub   
Diabetic peripheral neuropathy (DPN) is one of the most prevalent chronic complications of diabetes. The lifetime prevalence of DPN is thought to be >50%, and 15%–25% of patients with diabetes experience neuropathic pain, referred to as “painful DPN.” Appropriate treatment of painful DPN is important because this pain contributes to a poor quality of life by causing sleep disturbance, anxiety, and depression. The basic principle for the management of painful DPN is to control hyperglycemia and other modifiable risk factors, but these may be insufficient for preventing or improving DPN. Because there is no promising diseasemodifying medication for DPN, the pain itself needs to be managed when treating painful DPN. Drugs for neuropathic pain, such as gabapentinoids, serotonin–norepinephrine reuptake inhibitors, tricyclic antidepressants, alpha-lipoic acid, sodium channel blockers, and topical capsaicin, are used for the management of painful DPN. The U.S. Food and Drug Administration (FDA) has approved pregabalin, duloxetine, tapentadol, and the 8% capsaicin patch as drugs for the treatment of painful DPN. Recently, spinal cord stimulation using electrical stimulation is approved by the FDA for the treatment for painful DPN. This review describes the currently available pharmacological and nonpharmacological treatments for painful DPN.

Citations

Citations to this article as recorded by  
  • Diabetic peripheral neuropathy and neuromodulation techniques: a systematic review of progress and prospects
    Rahul Mittal, Keelin McKenna, Grant Keith, Evan McKenna, Joana R. N. Lemos, Jeenu Mittal, Khemraj Hirani
    Neural Regeneration Research.2025; 20(8): 2218.     CrossRef
  • A comprehensive review on sustainable strategies for valorization of pepper waste and their potential application
    Keithellakpam Sanatombi
    Comprehensive Reviews in Food Science and Food Safety.2025;[Epub]     CrossRef
  • Enhanced therapy for diabetic neuropathy utilizing venlafaxine hydrochloride-loaded transferosome-based transdermal gel
    Kajol Patil, Pramod S. Salve, Ujban Md Hussain Hussain, Amol Tatode, Mohammad Qutub
    Nano Trends.2025; 9: 100085.     CrossRef
  • Fast Analgesic Effect in Response Test with Topical Phenytoin Cream Correlates with Prolonged Pain Relief After Extended Use in Painful Diabetic Neuropathy
    David J. Kopsky, Alexander F. J. E. Vrancken, Ruben P. A. van Eijk, Ricardo Alvarez-Jimenez, Karolina M. Szadek, Remko Liebregts, Monique A. H. Steegers
    Pharmaceuticals.2025; 18(2): 228.     CrossRef
  • High‐Field Diffusion Tensor Imaging of Median, Tibial, and Sural Nerves in Type 2 Diabetes With Morphometric Analysis
    Luka Pušnik, Aljoša Gabor, Barbora Radochová, Jiří Janáček, František Saudek, Armin Alibegović, Igor Serša, Erika Cvetko, Nejc Umek, Žiga Snoj
    Journal of Neuroimaging.2025;[Epub]     CrossRef
  • Neuropathic pain management: a focused review of current treatments and novel data from main ongoing clinical trials
    Nikola Andrejic, Ivo Božovic, Hadi Moradi, Rojin Tataei, Nebojsa Nick Knezevic
    Expert Opinion on Investigational Drugs.2025; : 1.     CrossRef
  • Comprehensive approach to the rehabilitation of professionals with high levels of psychophysical stress, pain syndromes and type 2 diabetes mellitus during the war
    Lidiia V. Butska, Oksana O. Drevitska, Sergei V. Dybkalyuk, Valentyn O. Ryzhak
    Polski Merkuriusz Lekarski.2025; 53(1): 34.     CrossRef
  • Role of Mitochondrial Dysfunction in Neuropathy
    Nidia Espinoza, Vassilios Papadopoulos
    International Journal of Molecular Sciences.2025; 26(7): 3195.     CrossRef
  • Commentary: Analysis of risk factors for painful diabetic peripheral neuropathy and construction of a prediction model based on Lasso regression
    Bingdi Wei, Yao Liu, Xiaorui Liu, Chaojun Wei
    Frontiers in Endocrinology.2025;[Epub]     CrossRef
  • Sigma-1 receptor as an emerging target for painful diabetic neuropathy—a review
    Youyi Peng, Qiang Zhang, Shan Chen
    Exploration of Neuroscience.2025;[Epub]     CrossRef
  • Klinische Pharmakologie von Opioidanalgetika
    Constanze Rémi, Jennifer Berner, Aleksandra Dukic-Ott, Christina Hepperle
    Der Schmerz.2025;[Epub]     CrossRef
  • J-2156, a small molecule somatostatin type 4 receptor agonist, alleviated hindpaw hypersensitivity in the streptozotocin-induced rat model of painful diabetic neuropathy but with a 2-fold decrease in potency at an advanced stage in the model, mimicking mo
    A. Kuo, M. Z. Imam, R. Li, L. Lin, A. Raboczyj, A. E. Bohmer, J. R. Nicholson, L. Corradini, M. T. Smith
    Frontiers in Pharmacology.2024;[Epub]     CrossRef
  • The Chronic Wound–Related Pain Model
    Kevin Woo
    Clinics in Geriatric Medicine.2024; 40(3): 501.     CrossRef
  • Diabetic Neuropathy: A Guide to Pain Management
    Emily X. Zhang, Cyrus Yazdi, Rahib K. Islam, Ahmed I. Anwar, Alana Alvares-Amado, Horace Townsend, Kaitlyn E. Allen, Elena Plakotaris, Jon D. Hirsch, Ross G. Rieger, Varsha Allampalli, Jamal Hasoon, Kazi N. Islam, Sahar Shekoohi, Alan D. Kaye, Christopher
    Current Pain and Headache Reports.2024; 28(10): 1067.     CrossRef
  • Expert opinion on screening, diagnosis and management of diabetic peripheral neuropathy: a multidisciplinary approach
    Aysegul Atmaca, Aysegul Ketenci, Ibrahim Sahin, Ihsan Sukru Sengun, Ramazan Ilyas Oner, Hacer Erdem Tilki, Mine Adas, Hatice Soyleli, Tevfik Demir
    Frontiers in Endocrinology.2024;[Epub]     CrossRef
  • Predicting the efficacy of rehabilitation in patients with type 2 diabetes and diabetic polyneuropathy
    T.H. Bakaliuk, N.R. Makarchuk, H.O. Stelmakh, V.I. Pankiv, I.I. Kamyshna
    INTERNATIONAL JOURNAL OF ENDOCRINOLOGY (Ukraine).2024; 20(3): 155.     CrossRef
  • Xiaoke Bitong capsule alleviates inflammatory impairment via inhibition of the TNF signaling pathway to against diabetic peripheral neuropathy
    Lulu Tian, Meiqi Yang, Shanjie Tu, Kaixin Chang, Huanyu Jiang, Yuwei Jiang, Lu Ding, Zhiwei Weng, Yueqiang Wang, Xiaolong Tan, Chunxiao Zong, Buyang Chen, Xiaobing Dou, Xiuge Wang, Xuchen Qi
    Phytomedicine.2024; 132: 155867.     CrossRef
  • Exploring the Efficacy of Alpha-Lipoic Acid in Comorbid Osteoarthritis and Type 2 Diabetes Mellitus
    Iryna Halabitska, Valentyn Oksenych, Oleksandr Kamyshnyi
    Nutrients.2024; 16(19): 3349.     CrossRef
  • Research Progress of Coenzyme Q in Diabetes Mellitus and Its Common Complications
    Jingdong Xia, Xiudan Li, Chunying Bai, Xuchen Han
    Diabetes, Metabolic Syndrome and Obesity.2024; Volume 17: 3629.     CrossRef
  • Negative allosteric modulator of Group Ⅰ mGluRs: Recent advances and therapeutic perspective for neuropathic pain
    Jia-Ling Li, Chun-Hao Zhu, Miao-Miao Tian, Yue Liu, Lin Ma, Li-Jun Tao, Ping Zheng, Jian-Qiang Yu, Ning Liu
    Neuroscience.2024; 560: 406.     CrossRef
  • A Missing Puzzle in Preclinical Studies—Are CCR2, CCR5, and Their Ligands’ Roles Similar in Obesity-Induced Hypersensitivity and Diabetic Neuropathy?—Evidence from Rodent Models and Clinical Studies
    Aleksandra Bober, Joanna Mika, Anna Piotrowska
    International Journal of Molecular Sciences.2024; 25(20): 11323.     CrossRef
  • Bibliometric and visualized analysis of 2014–2024 publications on therapy for diabetic peripheral neuropathy
    Baitian Fu, Ning Luo, Yichen Zeng, Yutian Chen, Low Je Wie, Jianqiao Fang
    Frontiers in Neuroscience.2024;[Epub]     CrossRef
  • The neuroprotective effects of progesterone against peripheral neuropathy: a systematic review of non-clinical studies
    Hamed Haghi-Aminjan, Mahsa Kouhestani, Asieh Hosseini
    Metabolic Brain Disease.2024;[Epub]     CrossRef
  • The irreversible, towards fatalic neuropathy: from the genesis of diabetes
    Bhaskar Pal, Rashmi Ghosh, Raktimava Das Sarkar, Gouranga Sundar Roy
    Acta Diabetologica.2024; 62(2): 139.     CrossRef
  • Transcutaneous Electrical Nerve Stimulation and Aerobic Exercise for Alcohol-Related Peripheral Neuropathy: A Case Report
    Yuto Niwa, Manabu Nankaku, Ryosuke Ikeguchi
    Cureus.2024;[Epub]     CrossRef
Complications
Article image
Dyslipidemia in Patients with Chronic Kidney Disease: An Updated Overview
Sang Heon Suh, Soo Wan Kim
Diabetes Metab J. 2023;47(5):612-629.   Published online July 24, 2023
DOI: https://doi.org/10.4093/dmj.2023.0067
  • 13,977 View
  • 1,011 Download
  • 23 Web of Science
  • 25 Crossref
AbstractAbstract PDFPubReader   ePub   
Dyslipidemia is a potentially modifiable cardiovascular risk factor. Whereas the recommendations for the treatment target of dyslipidemia in the general population are being more and more rigorous, the 2013 Kidney Disease: Improving Global Outcomes clinical practice guideline for lipid management in chronic kidney disease (CKD) presented a relatively conservative approach with respect to the indication of lipid lowering therapy and therapeutic monitoring among the patients with CKD. This may be largely attributed to the lack of high-quality evidence derived from CKD population, among whom the overall feature of dyslipidemia is considerably distinctive to that of general population. In this review article, we cover the characteristic features of dyslipidemia and impact of dyslipidemia on cardiovascular outcomes in patients with CKD. We also review the current evidence on lipid lowering therapy to modify the risk of cardiovascular events in this population. We finally discuss the association between dyslipidemia and CKD progression and the potential strategy to delay the progression of CKD in relation to lipid lowering therapy.

Citations

Citations to this article as recorded by  
  • Impact of remnant cholesterol on short-term and long-term prognosis in patients with prediabetes or diabetes undergoing coronary artery bypass grafting: a large-scale cohort study
    Zhongchen Li, Chunyu Yu, Heng Zhang, Runze Chen, Yan Zhao, Zhe Zheng
    Cardiovascular Diabetology.2025;[Epub]     CrossRef
  • Effects of Tocotrienol on Cardiovascular Risk Markers in Patients With Chronic Kidney Disease: A Randomized Controlled Trial
    Liana Trugilho, Lívia Alvarenga, Ludmila Cardozo, Bruna Paiva, Jessyca Brito, Isis Barboza, Jonatas Almeida, Juliana dos Anjos, Pramod Khosla, Marcelo Ribeiro-Alves, Denise Mafra, Eric Gumpricht
    Journal of Nutrition and Metabolism.2025;[Epub]     CrossRef
  • The Impact of Glomerular Disease on Dyslipidemia in Pediatric Patients Treated with Dialysis
    Edward Zitnik, Elani Streja, Marciana Laster
    Nutrients.2025; 17(3): 459.     CrossRef
  • Diabetes, Chronic Kidney Disease, and Vascular Ulcers: Prevention Strategies and Clinical Implications
    Stefano Mancin, Alfonso Zarrella, Fabio Petrelli, Simone Cosmai, Daniela Cattani, Diego Lopane, Sarah Scollo, Sara Morales Palomares, Marco Sguanci, Antonella Amendola, Giovanni Cangelosi, Beatrice Mazzoleni
    Diabetology.2025; 6(2): 10.     CrossRef
  • Cardiovascular disease burden and associated risk factors in chronic kidney disease
    Roshan Bhandari, Srijan Pantha, Ghanashyam Pandey, Richa Paudyal
    Indian Journal of Medical Sciences.2025; 0: 1.     CrossRef
  • Association of the Triglyceride-Glucose Index with Body Composition and Laboratory Parameters in Chronic Kidney Disease Stages 3–5
    Shan-Shan Xu, Yan-Meng Guan, Hong-Yun Xuan, Xiu-Fang Fan, Ping Lu, Li-Hai Hao
    Risk Management and Healthcare Policy.2025; Volume 18: 903.     CrossRef
  • The association between non-high-density lipoprotein cholesterol to high-density lipoprotein cholesterol ratio and pulmonary function: evidence from NHANES 2007–2012
    Miaoyan Liu, Chaofeng Gao, Jinggeng Li, Yibo Zhang, Rui Gao, Chaoting Yang, Jian Zhang
    Frontiers in Nutrition.2025;[Epub]     CrossRef
  • Dietary butyric acid intake, kidney function, and survival: The National Health and Nutrition Examination Surveys, 2005–2018
    Wei Tang, Zhengyi Long, Yang Xiao, Jingyun Du, Chenyuan Tang, JunXiang Chen, Can Hou
    Clinical Nutrition ESPEN.2025; 67: 453.     CrossRef
  • From fat to filter: the effect of adipose tissue-derived signals on kidney function
    Nermin Ahmed, Carolina Dalmasso, Meghan B. Turner, Gertrude Arthur, Cole Cincinelli, Analia S. Loria
    Nature Reviews Nephrology.2025;[Epub]     CrossRef
  • CHANGES IN CENTRAL AORTIC PRESSURE AND ARTERIAL STIFFNESS IN YOUNG MEN WITH ARTERIAL HYPERTENSION AND CHRONIC KIDNEY DISEASE
    O. M. Bilovol, I. I. Kniazkova, V. O. Golovachova, N. V. Kuzminova, D. О. Kіrienko, O. M. Kіrienko, L. P. Abramova
    World of Medicine and Biology.2025; 21(91): 26.     CrossRef
  • Analysis of the association between long-term exposure to low-dose ionizing radiation and dyslipidemia and its components in medical radiologists: The mediating role of inflammatory markers
    Changyong Wen, Xiaolian Liu, Yiqing Lian, Weizhen Guo, Lingyu Zhang, Yanting Chen, Xin Lan, Mingfang Li, Sufen Zhang, Weixu Huang, Jianming Zou, Huifeng Chen
    International Journal of Cardiology Cardiovascular Risk and Prevention.2025; 25: 200406.     CrossRef
  • The protective effect of dietary sphingomyelin supplementation against impaired lipid metabolism in obese mice: a systematic review and meta-analysis of randomized controlled trials
    Xiao-Yan Qin, Jie Pan, Yi-Na Liu, Hui-Min Luo, Fang Yang
    Food, Nutrition and Health.2025;[Epub]     CrossRef
  • Statin Therapy and Lipid Indices in Chronic Kidney Disease: A Systematic Review and Meta-analysis of Randomized Control Trials
    Jafar Karami, Bahman Razi, Danyal Imani, Saeed Aslani, Mahdi Pakjoo, Mahdieh Fasihi, Keyhan Mohammadi, Amirhossein Sahebkar
    Current Pharmaceutical Design.2024; 30(5): 362.     CrossRef
  • Lipoprotein glomerulopathy with markedly increased arterial stiffness successfully treated with a combination of fenofibrate and losartan: a case report
    Junichiro Kato, Hideo Okonogi, Go Kanzaki, Haruki Katsumata, Yasuyuki Nakada, Makoto Sagasaki, Kazumasa Komine, Kenji Ito, Takao Saito, Akira Matsunaga, Koh Tokutou, Kazuho Honda, Nobuo Tsuboi, Takashi Yokoo
    BMC Nephrology.2024;[Epub]     CrossRef
  • Atherogenic index of plasma: a new indicator for assessing the short-term mortality of patients with acute decompensated heart failure
    Meng Yu, Hongyi Yang, Maobin Kuang, Jiajun Qiu, Changhui Yu, Guobo Xie, Guotai Sheng, Yang Zou
    Frontiers in Endocrinology.2024;[Epub]     CrossRef
  • Association between lipid accumulation product index and chronic kidney disease: A systematic review and meta-analysis
    Feixiang Wu, Chenmin Cui, Junping Wu, Yunqing Wang
    Experimental and Therapeutic Medicine.2024;[Epub]     CrossRef
  • Potential impact of sodium glucose co-transporter (SGLT2) inhibitors on cholesterol fractions in stage 3 chronic kidney disease
    Rabab Mahmoud Ahmed, Nehal Kamal Rakha, Ahmed Yousry, Amin Roshdy Soliman
    The Egyptian Journal of Internal Medicine.2024;[Epub]     CrossRef
  • Pulmonary Hypertension in Hemodialysis Patients and Its Determinants: A Hospital Based Cross-Sectional Study
    Qingfei Yu, Qin Zhang
    International Journal of General Medicine.2024; Volume 17: 3919.     CrossRef
  • Relationship Between Serum Uromodulin as a Marker of Kidney Damage and Metabolic Status in Patients with Chronic Kidney Disease of Non-Diabetic Etiology
    Radmila Žeravica, Branislava Ilinčić, Dragan Burić, Ana Jakovljević, Veljko Crnobrnja, Dalibor Ilić, Marija Vukmirović Papuga
    International Journal of Molecular Sciences.2024; 25(20): 11159.     CrossRef
  • Dyslipidemia in Peritoneal Dialysis: Implications for Peritoneal Membrane Function and Patient Outcomes
    Natalia Stepanova
    Biomedicines.2024; 12(10): 2377.     CrossRef
  • Causal associations between kidney function and aortic valve stenosis: a bidirectional Mendelian randomization analysis
    Wanqian Pan, Le Zhou, Rui Han, Xiaojiao Du, Weixiang Chen, Tingbo Jiang
    Renal Failure.2024;[Epub]     CrossRef
  • U-shaped association between dietary niacin intake and chronic kidney disease among US elderly: a nationwide cross-sectional study
    Zhouzhou Xie, Shansen Peng, Gejun Ou, Xiaoqi Zhou, Guihao Zhang, Huiming Jiang, Tianhui Zhang, Nanhui Chen
    Frontiers in Endocrinology.2024;[Epub]     CrossRef
  • Association between dried fruit intake and kidney function: research from univariate and multivariate Mendelian randomized studies
    Yuhang Gao, Xinghai Yue, Wanchao Zhao, Fang Yuan
    Frontiers in Nutrition.2024;[Epub]     CrossRef
  • The Dual Burden: Exploring Cardiovascular Complications in Chronic Kidney Disease
    Alfredo Caturano, Raffaele Galiero, Maria Rocco, Giuseppina Tagliaferri, Alessia Piacevole, Davide Nilo, Giovanni Di Lorenzo, Celestino Sardu, Vincenzo Russo, Erica Vetrano, Marcellino Monda, Raffaele Marfella, Luca Rinaldi, Ferdinando Carlo Sasso
    Biomolecules.2024; 14(11): 1393.     CrossRef
  • Association between the EHBP1 SNPs and dyslipidemia in the end-stage renal disease patients with dialysis in Chinese Han population
    Yan-Fei Lai, Zhong-E Liang, Chun-Xiang Wu, Min Zhang, Zong-Hu Shi, Xiao-Yan Meng, Chun-Xiao Liu
    Lipids in Health and Disease.2024;[Epub]     CrossRef
Metabolic Risk/Epidemiology
Article image
Glucagon-Like Peptide-1: New Regulator in Lipid Metabolism
Tong Bu, Ziyan Sun, Yi Pan, Xia Deng, Guoyue Yuan
Diabetes Metab J. 2024;48(3):354-372.   Published online April 1, 2024
DOI: https://doi.org/10.4093/dmj.2023.0277
  • 38,147 View
  • 1,272 Download
  • 21 Web of Science
  • 24 Crossref
AbstractAbstract PDFPubReader   ePub   
Glucagon-like peptide-1 (GLP-1) is a 30-amino acid peptide hormone that is mainly expressed in the intestine and hypothalamus. In recent years, basic and clinical studies have shown that GLP-1 is closely related to lipid metabolism, and it can participate in lipid metabolism by inhibiting fat synthesis, promoting fat differentiation, enhancing cholesterol metabolism, and promoting adipose browning. GLP-1 plays a key role in the occurrence and development of metabolic diseases such as obesity, nonalcoholic fatty liver disease, and atherosclerosis by regulating lipid metabolism. It is expected to become a new target for the treatment of metabolic disorders. The effects of GLP-1 and dual agonists on lipid metabolism also provide a more complete treatment plan for metabolic diseases. This article reviews the recent research progress of GLP-1 in lipid metabolism.

Citations

Citations to this article as recorded by  
  • Incretin hormones: Revolutionizing the treatment landscape for kidney and liver diseases in type 2 diabetes and obesity
    Jae Hyun Bae, Young Min Cho
    Journal of Diabetes Investigation.2025; 16(2): 183.     CrossRef
  • Lipoprotein(a) in atherosclerotic cardiovascular disease, type 2 diabetes, and liver disease
    Kathryn L. Williams, Maya Augustine, Eru Sujakhu, Justine Magadia, Lindsay Crawford, Aimee Knott, Skyler Hamilton, Uzoma Obiaka
    Progress in Pediatric Cardiology.2025; 76: 101775.     CrossRef
  • The protective effects of liraglutide in reducing lipid droplets accumulation and myocardial fibrosis in diabetic cardiomyopathy
    Chien-Yin Kuo, Sing-Hua Tsou, Edy Kornelius, Kuei-Chuan Chan, Kai-Wei Chang, Jung-Chi Li, Chien-Ning Huang, Chih-Li Lin
    Cellular and Molecular Life Sciences.2025;[Epub]     CrossRef
  • An oral liraglutide nanomicelle formulation conferring reduced insulin-resistance and long-term hypoglycemic and lipid metabolic benefits
    Laxman Subedi, Arjun Dhwoj Bamjan, Susmita Phuyal, Jung-Hyun Shim, Seung-Sik Cho, Jong Bae Seo, Kwan-Young Chang, Youngro Byun, Seho Kweon, Jin Woo Park
    Journal of Controlled Release.2025; 378: 637.     CrossRef
  • Engineering a high‐throughput clone for industrial‐scale production of long‐acting GLP‐1 analogue with retained bio‐efficacy
    Praveen Kumar Reddy J, Murali Tummuru, Kunka Mohanram Ramkumar
    Biotechnology Progress.2025;[Epub]     CrossRef
  • Role of molecular hydrogen in obesity treatment: modulation of GLP-1, irisin, and PGC-1α for improved metabolism
    Nikola Todorović, Jovan Kuzmanovic, Dejan Javorac, Sergej M. Ostojic
    Medical Gas Research.2025; 15(3): 442.     CrossRef
  • Association between GLP-1 RAs and DPP-4 inhibitors with biliary disorders: pharmacovigilance analysis
    Long He, Jinwei Li, Xiong Cheng, Li Luo, Yilan Huang
    Frontiers in Pharmacology.2025;[Epub]     CrossRef
  • Glucagon like peptide-1 receptor agonists as a promising therapeutic option of metabolic dysfunction associated steatotic liver disease and obesity: hitting two targets with one shot
    Eda Kaya, Wing-Kin Syn, Paul Manka
    Current Opinion in Gastroenterology.2025; 41(3): 104.     CrossRef
  • 2FA-Platform Generates Dual Fatty Acid-Conjugated GLP-1 Receptor Agonist TE-8105 with Enhanced Diabetes, Obesity, and NASH Efficacy Compared to Semaglutide
    Mun-Teng Wong, Pei-Hsuan Lin, Wei-Chen Lin, Chi-Jiun Peng, Jon D. Wright, Hui-Ju Lee, Hsing-Mao Chu, Carmay Lim, Tse Wen Chang
    Journal of Medicinal Chemistry.2025; 68(6): 6178.     CrossRef
  • Perioperative Considerations of Novel Antidiabetic Agents in Heart Failure Patients Undergoing Cardiac Surgery
    Ashley Wang, Savannah Bitzas, Dilsa Perez, Jonathon Schwartz, Saleem Zaidi, Jonathan Oster, Sergio D. Bergese
    Life.2025; 15(3): 427.     CrossRef
  • The Role of GLP-1RA Medications in Medical Weight Loss and the Positive Impacts on Lipid Management
    Blair Suter, Allison Rhodes, Allison Bigeh, Timothy Frommeyer, Laxmi S. Mehta
    Current Cardiovascular Risk Reports.2025;[Epub]     CrossRef
  • The Role of Short-Chain Fatty Acids in Metabolic Dysfunction-Associated Steatotic Liver Disease and Other Metabolic Diseases
    Eliane Münte, Phillipp Hartmann
    Biomolecules.2025; 15(4): 469.     CrossRef
  • Vertical sleeve gastrectomy and semaglutide have distinct effects on skeletal health and heart function in obese male mice
    Caroline de Carvalho Picoli, Sergey Tsibulnikov, Mavy Ho, Victoria DeMambro, Tiange Feng, May Eltahir, Phuong T. Le, Carolyn Chlebek, Clifford J. Rosen, Sergey Ryzhov, Ziru Li
    American Journal of Physiology-Endocrinology and Metabolism.2025; 328(4): E555.     CrossRef
  • Pre-fertilization-origin preservation of brown fat-mediated energy expenditure in humans
    Takeshi Yoneshiro, Mami Matsushita, Sayuri Fuse-Hamaoka, Miyuki Kuroiwa, Yuko Kurosawa, Yosuke Yamada, Makoto Arai, Yuchen Wei, Makoto Iida, Kenichi Kuma, Toshimitsu Kameya, Tomoya Harada, Yoshihiro Matsumura, Tsuyoshi Osawa, Yoshiko Aoki, Hisashi Nakamur
    Nature Metabolism.2025; 7(4): 778.     CrossRef
  • Comparing Efficacy of Chiglitazar, Pioglitazone, and Semaglutide in Type 2 Diabetes: A Retrospective Study
    Wenxuan Li, Yangang Wang, Chuanfeng Liu, Yongzhuo Yu, Lili Xu, Bingzi Dong
    Diabetes Therapy.2025; 16(5): 993.     CrossRef
  • Liraglutide Attenuates FFA-Induced Retinal Pigment Epithelium Dysfunction via AMPK Activation and Lipid Homeostasis Regulation in ARPE-19 Cells
    Sing-Hua Tsou, Kai-Shin Luo, Chien-Ning Huang, Edy Kornelius, I-Ting Cheng, Hui-Chih Hung, Yu-Chien Hung, Chih-Li Lin, Min-Yen Hsu
    International Journal of Molecular Sciences.2025; 26(8): 3704.     CrossRef
  • Diabetes and Osteoarthritis: Exploring the Interactions and Therapeutic Implications of Insulin, Metformin, and GLP-1-Based Interventions
    Iryna Halabitska, Liliia Babinets, Valentyn Oksenych, Oleksandr Kamyshnyi
    Biomedicines.2024; 12(8): 1630.     CrossRef
  • The Effect of Tirzepatide on Body Composition in People with Overweight and Obesity: A Systematic Review of Randomized, Controlled Studies
    Vincenzo Rochira, Carla Greco, Stefano Boni, Francesco Costantino, Leonardo Dalla Valentina, Eleonora Zanni, Leila Itani, Marwan El Ghoch
    Diseases.2024; 12(9): 204.     CrossRef
  • Glucagon-like peptide-1 receptor: mechanisms and advances in therapy
    Zhikai Zheng, Yao Zong, Yiyang Ma, Yucheng Tian, Yidan Pang, Changqing Zhang, Junjie Gao
    Signal Transduction and Targeted Therapy.2024;[Epub]     CrossRef
  • Recent Advances and Therapeutic Benefits of Glucagon-Like Peptide-1 (GLP-1) Agonists in the Management of Type 2 Diabetes and Associated Metabolic Disorders
    John O Olukorode, Dolapo A Orimoloye, Nwachukwu O Nwachukwu, Chidera N Onwuzo, Praise O Oloyede, Temiloluwa Fayemi, Oluwatobi S Odunaike, Petra S Ayobami-Ojo, Nwachi Divine, Demilade J Alo, Chukwurah U Alex
    Cureus.2024;[Epub]     CrossRef
  • Interactions between glucagon like peptide 1 (GLP-1) and estrogens regulates lipid metabolism
    Jorge F.A. Model, Rafaella S. Normann, Éverton L. Vogt, Maiza Von Dentz, Marjoriane de Amaral, Rui Xu, Tsvetan Bachvaroff, Poli Mara Spritzer, J. Sook Chung, Anapaula S. Vinagre
    Biochemical Pharmacology.2024; 230: 116623.     CrossRef
  • Changes in 24-Hour Urine Chemistry in Patients with Nephrolithiasis during Weight Loss with Glucagon-Like Peptide 1–Based Therapies
    Karen Feghali, Xilong Li, Naim M. Maalouf
    Kidney360.2024; 5(11): 1706.     CrossRef
  • Liuweizhiji Gegen-Sangshen beverage protects against alcoholic liver disease in mice through the gut microbiota mediated SCFAs/GPR43/GLP-1 pathway
    Mingyun Tang, Long Zhao, Fuchun Huang, Tiangang Wang, Xu Wu, Shanshan Chen, Juan Fu, Chaoli Jiang, Shulin Wei, Xuseng Zeng, Xiaoling Zhang, Xin Zhou, Mei Wei, Zhi Li, Guohui Xiao
    Frontiers in Nutrition.2024;[Epub]     CrossRef
  • Spotlight on the Mechanism of Action of Semaglutide
    Ilias Papakonstantinou, Konstantinos Tsioufis, Vasiliki Katsi
    Current Issues in Molecular Biology.2024; 46(12): 14514.     CrossRef
Original Articles
Guideline/Fact Sheet
Article image
Fatty Liver & Diabetes Statistics in Korea: Nationwide Data 2009 to 2017
Eugene Han, Kyung-Do Han, Yong-ho Lee, Kyung-Soo Kim, Sangmo Hong, Jung Hwan Park, Cheol-Young Park, on Behalf of Fatty Liver Research Group of the Korean Diabetes Association
Diabetes Metab J. 2023;47(3):347-355.   Published online March 29, 2023
DOI: https://doi.org/10.4093/dmj.2022.0444
  • 6,732 View
  • 270 Download
  • 21 Web of Science
  • 22 Crossref
AbstractAbstract PDFSupplementary MaterialPubReader   ePub   
Background
This study investigated the changes of fatty liver disease prevalence in general Korean population.
Methods
This study analyzed data from the Korean National Health Insurance Service from 2009 to 2017 that included individuals aged 20 years or older who had undergone a medical health examination. Fatty liver disease was assessed using the fatty liver index (FLI). The disease severity was defined by FLI cutoff, ≥30 as moderate, and ≥60 as severe fatty liver disease.
Results
The prevalence of Korean adults aged 20 years or over with fatty liver disease (FLI ≥60) increased from 13.3% in 2009 to 15.5% in 2017 (P for trend <0.001). The increase in fatty liver disease prevalence was prominent in men (from 20.5% to 24.2%) and the young age (20 to 39 years) group (from 12.8% to 16.4%) (P for interaction <0.001). The prevalence of fatty liver disease was the highest in type 2 diabetes mellitus (T2DM, 29.6%) population compared to that of prediabetes or normoglycemia (10.0% and 21.8%) in 2017. The prevalence of fatty liver disease had statistically increased in individuals with T2DM and prediabetes (P for trend <0.001). Its prevalence increased more steeply in the young-aged population with T2DM, from 42.2% in 2009 to 60.1% in 2017. When applying a lower FLI cutoff (≥30) similar results were observed.
Conclusion
The prevalence of fatty liver disease in the Korean population has increased. Individuals who are young, male, and have T2DM are vulnerable to fatty liver disease.

Citations

Citations to this article as recorded by  
  • Liver Cancer Risk Across Metabolic Dysfunction-Associated Steatotic Liver Disease and/or Alcohol: A Nationwide Study
    Byungyoon Yun, Heejoo Park, Sang Hoon Ahn, Juyeon Oh, Beom Kyung Kim, Jin-Ha Yoon
    American Journal of Gastroenterology.2025; 120(2): 410.     CrossRef
  • Metabolic Dysfunction-Associated Steatotic Liver Disease and All-Cause and Cause-Specific Mortality
    Rosa Oh, Seohyun Kim, So Hyun Cho, Jiyoon Kim, You-Bin Lee, Sang-Man Jin, Kyu Yeon Hur, Gyuri Kim, Jae Hyeon Kim
    Diabetes & Metabolism Journal.2025; 49(1): 80.     CrossRef
  • Big Data Research for Diabetes-Related Diseases Using the Korean National Health Information Database
    Kyung-Soo Kim, Bongseong Kim, Kyungdo Han
    Diabetes & Metabolism Journal.2025; 49(1): 13.     CrossRef
  • Prevalence, Incidence, and Metabolic Characteristics of Young Adults with Type 2 Diabetes Mellitus in South Korea (2010–2020)
    Ji Yoon Kim, Jiyoon Lee, Joon Ho Moon, Se Eun Park, Seung-Hyun Ko, Sung Hee Choi, Nam Hoon Kim
    Diabetes & Metabolism Journal.2025; 49(2): 172.     CrossRef
  • Impact of steatotic liver disease categories on atrial fibrillation in type 2 diabetes: a nationwide study
    So Hyun Cho, Gyuri Kim, Kyu-na Lee, Rosa Oh, Ji Yoon Kim, Myunghwa Jang, You-Bin Lee, Sang-Man Jin, Kyu Yeon Hur, Kyungdo Han, Jae Hyeon Kim
    Scientific Reports.2025;[Epub]     CrossRef
  • Increased Risk of Early-Onset Endometrial Cancer in Women Aged 20–39 Years with Non-Alcoholic Fatty Liver Disease: A Nationwide Cohort Study
    Joo-Hyun Park, Jung Yong Hong, Kyungdo Han, Wonseok Kang, Jay J. Shen
    Cancers.2025; 17(8): 1322.     CrossRef
  • Longitudinal changes in fatty liver index are associated with risk of hepatocellular carcinoma: A nationwide cohort study in Korea
    Min Gu Kang, Chang Hun Lee, Chen Shen, Jong Seung Kim, Ji Hyun Park
    Journal of Hepatology.2024; 80(5): e216.     CrossRef
  • Repeated detection of non‐alcoholic fatty liver disease increases the incidence risk of type 2 diabetes in young adults
    Jin Hwa Kim, Young Sang Lyu, Mee Kyoung Kim, Sang Yong Kim, Ki‐Hyun Baek, Ki‐Ho Song, Kyungdo Han, Hyuk‐Sang Kwon
    Diabetes, Obesity and Metabolism.2024; 26(1): 180.     CrossRef
  • Mortality in metabolic dysfunction-associated steatotic liver disease: A nationwide population-based cohort study
    Eugene Han, Byung-Wan Lee, Eun Seok Kang, Bong-Soo Cha, Sang Hoon Ahn, Yong-ho Lee, Seung Up Kim
    Metabolism.2024; 152: 155789.     CrossRef
  • Association of non-alcoholic fatty liver disease with cardiovascular disease and all cause death in patients with type 2 diabetes mellitus: nationwide population based study
    Kyung-Soo Kim, Sangmo Hong, Kyungdo Han, Cheol-Young Park
    BMJ.2024; : e076388.     CrossRef
  • Hepatic Fibrosis and Cancer: The Silent Threats of Metabolic Syndrome
    Scott L. Friedman
    Diabetes & Metabolism Journal.2024; 48(2): 161.     CrossRef
  • Insulin Resistance, Non-Alcoholic Fatty Liver Disease and Type 2 Diabetes Mellitus: Clinical and Experimental Perspective
    Inha Jung, Dae-Jeong Koo, Won-Young Lee
    Diabetes & Metabolism Journal.2024; 48(3): 327.     CrossRef
  • Association between long working hours and metabolic dysfunction–associated steatotic liver disease: a nationwide population-based study in Korea
    S.-U. Baek, J.-U. Won, Y.-M. Lee, J.-H. Yoon
    Public Health.2024; 232: 188.     CrossRef
  • Association between Dietary Quality and Non-Alcoholic Fatty Liver Disease in Korean Adults: A Nationwide, Population-Based Study Using the Korean Healthy Eating Index (2013–2021)
    Seong-Uk Baek, Taeyeon Kim, Yu-Min Lee, Jong-Uk Won, Jin-Ha Yoon
    Nutrients.2024; 16(10): 1516.     CrossRef
  • Metabolic Dysfunction-Associated Steatotic Liver Disease Is Associated with Increased Risk of Kidney Cancer: A Nationwide Study
    Juyeon Oh, Beom Kyung Kim, Jin-Ha Yoon, Hyung Ho Lee, Heejoo Park, Jian Lee, Youngsun Park, Byungyoon Yun, Jinsoo Chung
    Cancers.2024; 16(18): 3161.     CrossRef
  • Metabolic Dysfunction-Associated Steatotic Liver Disease in Type 2 Diabetes Mellitus: A Review and Position Statement of the Fatty Liver Research Group of the Korean Diabetes Association
    Jaehyun Bae, Eugene Han, Hye Won Lee, Cheol-Young Park, Choon Hee Chung, Dae Ho Lee, Eun-Hee Cho, Eun-Jung Rhee, Ji Hee Yu, Ji Hyun Park, Ji-Cheol Bae, Jung Hwan Park, Kyung Mook Choi, Kyung-Soo Kim, Mi Hae Seo, Minyoung Lee, Nan-Hee Kim, So Hun Kim, Won-
    Diabetes & Metabolism Journal.2024; 48(6): 1015.     CrossRef
  • High-Sensitivity C-Reactive Protein Levels in Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD), Metabolic Alcohol-Associated Liver Disease (MetALD), and Alcoholic Liver Disease (ALD) with Metabolic Dysfunction
    Seong-Uk Baek, Jin-Ha Yoon
    Biomolecules.2024; 14(11): 1468.     CrossRef
  • Cumulative Burden of Fatty Liver and Kidney Cancer in Young Men: A National Population-Based Study
    Hee Yeon Lee, Kyung Do Han, Hyuk-Sang Kwon
    Journal of Clinical Medicine.2024; 14(1): 148.     CrossRef
  • Reply to G. Wang et al
    Joo-Hyun Park, Jung Yong Hong, Kyungdo Han
    Journal of Clinical Oncology.2023; 41(32): 5070.     CrossRef
  • The Role of the Fatty Liver Index (FLI) in the Management of Non-Alcoholic Fatty Liver Disease: A Systematic Review
    Teodora Biciusca, Sorina Ionelia Stan, Mara Amalia Balteanu, Ramona Cioboata, Alice Elena Ghenea, Suzana Danoiu, Ana-Maria Bumbea, Viorel Biciusca
    Diagnostics.2023; 13(21): 3316.     CrossRef
  • Lean or Non-obese Nonalcoholic Fatty Liver Disease Patients: Are They Really Lean?
    Eugene Han, Yong-ho Lee
    Clinical and Molecular Hepatology.2023; 29(4): 980.     CrossRef
  • Approach to Fatty Liver Disease in Patients with Type 2 Diabetes
    Ji Cheol Bae
    The Journal of Korean Diabetes.2023; 24(3): 107.     CrossRef
Drug/Regimen
Article image
Risk of Diabetic Retinopathy between Sodium-Glucose Cotransporter-2 Inhibitors and Glucagon-Like Peptide-1 Receptor Agonists
Tzu-Yi Lin, Eugene Yu-Chuan Kang, Shih-Chieh Shao, Edward Chia-Cheng Lai, Sunir J. Garg, Kuan-Jen Chen, Je-Ho Kang, Wei-Chi Wu, Chi-Chun Lai, Yih-Shiou Hwang
Diabetes Metab J. 2023;47(3):394-404.   Published online March 6, 2023
DOI: https://doi.org/10.4093/dmj.2022.0221
  • 9,596 View
  • 375 Download
  • 19 Web of Science
  • 22 Crossref
AbstractAbstract PDFSupplementary MaterialPubReader   ePub   
Background
To compare risk of diabetic retinopathy (DR) between patients taking sodium-glucose cotransporter-2 inhibitors (SGLT2is) and those taking glucagon-like peptide-1 receptor agonists (GLP1-RAs) in routine care.
Methods
This retrospective cohort study emulating a target trial included patient data from the multi-institutional Chang Gung Research Database in Taiwan. Totally, 33,021 patients with type 2 diabetes mellitus using SGLT2is and GLP1-RAs between 2016 and 2019 were identified. 3,249 patients were excluded due to missing demographics, age <40 years, prior use of any study drug, a diagnosis of retinal disorders, a history of receiving vitreoretinal procedure, no baseline glycosylated hemoglobin, or no follow-up data. Baseline characteristics were balanced using inverse probability of treatment weighting with propensity scores. DR diagnoses and vitreoretinal interventions served as the primary outcomes. Occurrence of proliferative DR and DR receiving vitreoretinal interventions were regarded as vision-threatening DR.
Results
There were 21,491 SGLT2i and 1,887 GLP1-RA users included for the analysis. Patients receiving SGLT2is and GLP-1 RAs exhibited comparable rate of any DR (subdistribution hazard ratio [SHR], 0.90; 95% confidence interval [CI], 0.79 to 1.03), whereas the rate of proliferative DR (SHR, 0.53; 95% CI, 0.42 to 0.68) was significantly lower in the SGLT2i group. Also, SGLT2i users showed significantly reduced risk of composite surgical outcome (SHR, 0.58; 95% CI, 0.48 to 0.70).
Conclusion
Compared to those taking GLP1-RAs, patients receiving SGLT2is had a lower risk of proliferative DR and vitreoretinal interventions, although the rate of any DR was comparable between the SGLT2i and GLP1-RA groups. Thus, SGLT2is may be associated with a lower risk of vision-threatening DR but not DR development.

Citations

Citations to this article as recorded by  
  • Impact of glucagon‐like peptide‐1 receptor agonists on diabetic retinopathy: A meta‐analysis of clinical studies emphasising retinal changes as a primary outcome
    Ishani Kapoor, Swara M. Sarvepalli, David A. D'Alessio, Majda Hadziahmetovic
    Clinical & Experimental Ophthalmology.2025; 53(1): 67.     CrossRef
  • SGLT2 inhibitors and diabetic retinopathy: Insights from the management of nephropathy
    Maria S. Varughese, Lakshminarayanan Varadhan
    Eye.2025; 39(2): 213.     CrossRef
  • Impact of Obstructive Sleep Apnea on Diabetic Retinopathy Progression and Systemic Complications
    Ehsan Rahimy, Euna B. Koo, Karen M. Wai, Cassie A. Ludwig, Andrea L. Kossler, Prithvi Mruthyunjaya
    American Journal of Ophthalmology.2025; 270: 93.     CrossRef
  • An update on ocular effects of antidiabetic medications
    Elham Sadeghi, Elham Rahmanipour, Nicola Valsecchi, Saloni Kapoor, Maria Vittoria Cicinelli, Jay Chhablani
    Survey of Ophthalmology.2025;[Epub]     CrossRef
  • Glucagon-like peptide-1 receptor agonists and the eye
    David L. Zhang, Avni P. Finn
    Current Opinion in Ophthalmology.2025;[Epub]     CrossRef
  • Incretin‐based drugs and the risk of diabetic retinopathy among individuals with type 2 diabetes: A systematic review and meta‐analysis of observational studies
    Samuel Igweokpala, Naheemot Olaoluwa Sule, Antonios Douros, Oriana H. Y. Yu, Kristian B. Filion
    Diabetes, Obesity and Metabolism.2024; 26(2): 721.     CrossRef
  • Association of sodium–glucose cotransporter‐2 inhibitors and the risk of retinal vascular occlusion: A real‐world retrospective cohort study in Taiwan
    Tzu‐Yi Lin, Eugene Yu‐Chuan Kang, Shih‐Chieh Shao, Edward Chia‐Cheng Lai, Nan‐Kai Wang, Sunir J. Garg, Kuan‐Jen Chen, Je‐Ho Kang, Wei‐Chi Wu, Chi‐Chun Lai, Yih‐Shiou Hwang
    Diabetes/Metabolism Research and Reviews.2024;[Epub]     CrossRef
  • Risk of rotator cuff tear and rotator cuff repair surgery comparison between sodium-glucose cotransporter 2 inhibitors and glucagon like peptide-1 receptor agonists: A real-world study
    Yu-Chi Su, Pei-Chun Hsieh, Edward Chia-Cheng Lai, Yu-Ching Lin
    Diabetes & Metabolism.2024; 50(2): 101522.     CrossRef
  • Optimising renal risk parameters in type 2 diabetes mellitus: Perspectives from a retinal viewpoint
    Sarita Jacob, George I. Varughese
    Clinical Medicine.2024; 24(2): 100031.     CrossRef
  • Risk of diabetic retinopathy and diabetic macular oedema with sodium–glucose cotransporter 2 inhibitors and glucagon-like peptide 1 receptor agonists in type 2 diabetes: a real-world data study from a global federated database
    Aikaterini Eleftheriadou, David Riley, Sizheng S. Zhao, Philip Austin, Gema Hernández, Gregory Y. H. Lip, Timothy L. Jackson, John P. H. Wilding, Uazman Alam
    Diabetologia.2024; 67(7): 1271.     CrossRef
  • Impact of GLP-1 Agonists and SGLT-2 Inhibitors on Diabetic Retinopathy Progression: An Aggregated Electronic Health Record Data Study
    Karen M. Wai, Kapil Mishra, Euna Koo, Cassie Ann Ludwig, Ravi Parikh, Prithvi Mruthyunjaya, Ehsan Rahimy
    American Journal of Ophthalmology.2024; 265: 39.     CrossRef
  • Comparative Effectiveness of Glucagon-Like Peptide-1 Receptor Agonists, Sodium-Glucose Cotransporter 2 Inhibitors, Dipeptidyl Peptidase-4 Inhibitors, and Sulfonylureas for Sight-Threatening Diabetic Retinopathy
    Andrew J. Barkmeier, Jeph Herrin, Kavya Sindhu Swarna, Yihong Deng, Eric C. Polley, Guillermo E. Umpierrez, Rodolfo J. Galindo, Joseph S. Ross, Mindy M. Mickelson, Rozalina G. McCoy
    Ophthalmology Retina.2024; 8(10): 943.     CrossRef
  • Association Between Pentoxifylline Use and Diabetic Retinopathy in Patients with Type 2 Diabetes Mellitus and Chronic Kidney Disease: A Multi-Institutional Cohort Study
    Tzu-Yi Lin, Eugene Yu-Chuan Kang, Nan-Kai Wang, Je-Ho Kang, Kuan-Jen Chen, Wei-Chi Wu, Chi-Chun Lai, Yih-Shiou Hwang
    Biomedical Journal.2024; : 100771.     CrossRef
  • Association between sodium-glucose cotransporter 2 inhibitors and eye disorders: a systematic review and meta-analysis
    Bo Xu, Bo Kang, Fan Tang, Jiecan Zhou, Zunbo He
    Expert Review of Clinical Pharmacology.2024; 17(10): 949.     CrossRef
  • Comparison of the Risk of Diabetic Retinopathy Between Sodium-Glucose Cotransporter-2 Inhibitors and Dipeptidyl Peptidase-4 Inhibitors in Patients with Type 2 Diabetes Mellitus in Japan: A Retrospective Analysis of Real-World Data
    Masaya Koshizaka, Tomoaki Tatsumi, Fumiko Kiyonaga, Yoshinori Kosakai, Yoko Yoshinaga, Mami Shintani-Tachi
    Diabetes Therapy.2024; 15(11): 2401.     CrossRef
  • NOVEL AGENTS IN THE MANAGEMENT OF DIABETES AND RISK OF WORSENING DIABETIC RETINOPATHY
    Rithwick Rajagopal, Janet B. McGill
    Retina.2024; 44(11): 1851.     CrossRef
  • Mechanism and therapeutic targets of circulating immune cells in diabetic retinopathy
    Bowen Zhao, Yin Zhao, Xufang Sun
    Pharmacological Research.2024; 210: 107505.     CrossRef
  • Diabetes Renders Photoreceptors Susceptible to Retinal Ischemia-Reperfusion Injury
    David A. Antonetti, Cheng-Mao Lin, Sumathi Shanmugam, Heather Hager, Manjing Cao, Xuwen Liu, Alyssa Dreffs, Adam Habash, Steven F. Abcouwer
    Investigative Ophthalmology & Visual Science.2024; 65(13): 46.     CrossRef
  • Multi-omics in exploring the pathophysiology of diabetic retinopathy
    Xinlu Li, XiaoJing Dong, Wen Zhang, Zhizhou Shi, Zhongjian Liu, Yalian Sa, Li Li, Ninghua Ni, Yan Mei
    Frontiers in Cell and Developmental Biology.2024;[Epub]     CrossRef
  • Risk of Diabetic Retinopathy between Sodium-Glucose Cotransporter-2 Inhibitors and Glucagon-Like Peptide-1 Receptor Agonists (Diabetes Metab J 2023;47:394-404)
    Tzu-Yi Lin, Eugene Yu-Chuan Kang, Shih-Chieh Shao, Edward Chia-Cheng Lai, Yih-Shiou Hwang
    Diabetes & Metabolism Journal.2023; 47(4): 573.     CrossRef
  • Risk of Diabetic Retinopathy between Sodium-Glucose Cotransporter-2 Inhibitors and Glucagon-Like Peptide-1 Receptor Agonists (Diabetes Metab J 2023;47:394-404)
    Jihee Ko, Sun Joon Moon
    Diabetes & Metabolism Journal.2023; 47(4): 571.     CrossRef
  • Sodium-Glucose Cotransporter 2 Inhibitors and Risk of Retinopathy in Patients With Type 2 Diabetes
    Fu-Shun Yen, James Cheng-Chung Wei, Teng-Shun Yu, Yu-Tung Hung, Chih-Cheng Hsu, Chii-Min Hwu
    JAMA Network Open.2023; 6(12): e2348431.     CrossRef
Review
Basic Research
Article image
The Link between Mitochondrial Dysfunction and Sarcopenia: An Update Focusing on the Role of Pyruvate Dehydrogenase Kinase 4
Min-Ji Kim, Ibotombi Singh Sinam, Zerwa Siddique, Jae-Han Jeon, In-Kyu Lee
Diabetes Metab J. 2023;47(2):153-163.   Published online January 12, 2023
DOI: https://doi.org/10.4093/dmj.2022.0305
  • 9,521 View
  • 546 Download
  • 20 Web of Science
  • 21 Crossref
AbstractAbstract PDFPubReader   ePub   
Sarcopenia, defined as a progressive loss of muscle mass and function, is typified by mitochondrial dysfunction and loss of mitochondrial resilience. Sarcopenia is associated not only with aging, but also with various metabolic diseases characterized by mitochondrial dyshomeostasis. Pyruvate dehydrogenase kinases (PDKs) are mitochondrial enzymes that inhibit the pyruvate dehydrogenase complex, which controls pyruvate entry into the tricarboxylic acid cycle and the subsequent adenosine triphosphate production required for normal cellular activities. PDK4 is upregulated in mitochondrial dysfunction-related metabolic diseases, especially pathologic muscle conditions associated with enhanced muscle proteolysis and aberrant myogenesis. Increases in PDK4 are associated with perturbation of mitochondria-associated membranes and mitochondrial quality control, which are emerging as a central mechanism in the pathogenesis of metabolic disease-associated muscle atrophy. Here, we review how mitochondrial dysfunction affects sarcopenia, focusing on the role of PDK4 in mitochondrial homeostasis. We discuss the molecular mechanisms underlying the effects of PDK4 on mitochondrial dysfunction in sarcopenia and show that targeting mitochondria could be a therapeutic target for treating sarcopenia.

Citations

Citations to this article as recorded by  
  • Repairing muscle with broccoli-derived sulforaphane: A preclinical evaluation for the treatment of mitochondrial myopathies
    Thomas Lilley, Donny M. Camera, Faith A.A. Kwa
    Drug Discovery Today.2025; 30(1): 104283.     CrossRef
  • Could Sarcopenia Be Related to Chemotherapy in Gastrointestinal Cancer? A Cross-Sectional Study Including Comprehensive Geriatric Assessment
    Kamile Sılay, Gökhan Uçar, Tülay Eren, Hande Selvi Öztorun, Ozan Yazıcı, Nuriye Özdemir
    Journal of Clinical Medicine.2025; 14(3): 711.     CrossRef
  • The association of body roundness index and body mass index with frailty and all-cause mortality: a study from the population aged 40 and above in the United States
    Jianqiang Zhang, Huifeng Zhang
    Lipids in Health and Disease.2025;[Epub]     CrossRef
  • Near Infrared‐Mediated Intracellular NADH Delivery Strengthens Mitochondrial Function and Stability in Muscle Dysfunction Model
    Hui Bang Cho, Hye‐Ryoung Kim, Sujeong Lee, Chae Won Cho, Ji‐In Park, Seulki Youn, Gyuwon So, Sumin Kang, Hye Jin Kim, Keun‐Hong Park
    Advanced Science.2025;[Epub]     CrossRef
  • The Association Between Low Muscle Mass and the Risk of Depressive Symptoms: A Cross‐Sectional Study Based on the Chinese Longitudinal Health Longevity Survey (CLHLS)
    Yuting Yang, Yan Wang, Qiao Chen, Ling Li, Wangping Jia
    Brain and Behavior.2025;[Epub]     CrossRef
  • Type 3 diabetes and metabolic reprogramming of brain neurons: causes and therapeutic strategies
    Xiangyuan Meng, Hui Zhang, Zhenhu Zhao, Siyao li, Xin Zhang, Ruihan Guo, Huimin Liu, Yiling Yuan, Wanrui Li, Qi Song, Jinyu Liu
    Molecular Medicine.2025;[Epub]     CrossRef
  • Dipalmitoylphosphatidylcholine Lipid Vesicles for Delivering HMB, NMN, and L-Leucine in Sarcopenia Therapy
    Alfred Najm, Alexandra Cătălina Bîrcă, Adelina-Gabriela Niculescu, Adina Alberts, Alexandru Mihai Grumezescu, Bianca Gălățeanu, Bogdan Ștefan Vasile, Mircea Beuran, Bogdan Severus Gaspar, Ariana Hudiță
    Molecules.2025; 30(7): 1437.     CrossRef
  • Synthesis, activatory effects, molecular docking and ADME studies as rabbit muscle pyruvate kinase activators of ureido phenyl substituted 1,4-dihydropyridine derivatives
    Mustafa Oğuzhan Kaya, Tuna Demirci, Ümit Çalışır, Oğuzhan Özdemir, Yeşim Kaya, Mustafa Arslan
    Research on Chemical Intermediates.2024; 50(1): 437.     CrossRef
  • Unraveling the causes of sarcopenia: Roles of neuromuscular junction impairment and mitochondrial dysfunction
    Yanmei Miao, Leiyu Xie, Jiamei Song, Xing Cai, Jinghe Yang, Xinglong Ma, Shaolin Chen, Peng Xie
    Physiological Reports.2024;[Epub]     CrossRef
  • Metabolic clues to aging: exploring the role of circulating metabolites in frailty, sarcopenia and vascular aging related traits and diseases
    Zonghao Qian, Yuzhen Huang, Yucong Zhang, Ni Yang, Ziwei Fang, Cuntai Zhang, Le Zhang
    Frontiers in Genetics.2024;[Epub]     CrossRef
  • Inhibition of Pyruvate Dehydrogenase Kinase 4 Protects Cardiomyocytes from lipopolysaccharide-Induced Mitochondrial Damage by Reducing Lactate Accumulation
    Tangtian Chen, Qiumin Xie, Bin Tan, Qin Yi, Han Xiang, Rui Wang, Qin Zhou, Bolin He, Jie Tian, Jing Zhu, Hao Xu
    Inflammation.2024; 47(4): 1356.     CrossRef
  • Effect of resistance training plus enriched probiotic supplement on sestrin2, oxidative stress, and mitophagy markers in elderly male Wistar rats
    Majid Mohabbat, Hamid Arazi
    Scientific Reports.2024;[Epub]     CrossRef
  • Comparison between single-muscle evaluation and cross-sectional area muscle evaluation for predicting the prognosis in patients with oral squamous cell carcinoma: a retrospective cohort study
    Hirotaka Takayama, Takuya Yoshimura, Hajime Suzuki, Yuka Hirano, Masahiro Tezuka, Takayuki Ishida, Kiyohide Ishihata, Marie Amitani, Haruka Amitani, Yasunori Nakamura, Yasushi Imamura, Akio Inui, Norifumi Nakamura
    Frontiers in Oncology.2024;[Epub]     CrossRef
  • Resveratrol and Vitamin D: Eclectic Molecules Promoting Mitochondrial Health in Sarcopenia
    Cristina Russo, Maria Stella Valle, Floriana D’Angeli, Sofia Surdo, Lucia Malaguarnera
    International Journal of Molecular Sciences.2024; 25(14): 7503.     CrossRef
  • Unveiling the crucial role of peroxisomal acyl-CoA metabolism in muscle atrophy: Insights from genetic models and therapeutic interventions
    Songling Jiang, Han Sol Kim, Ji Hyun Ryu, Yong-Soo Lee, Dong-Ik Kim, Eun-Jung Jin
    Nano Today.2024; 58: 102417.     CrossRef
  • Dichloroacetate Prevents Sepsis Associated Encephalopathy by Inhibiting Microglia Pyroptosis through PDK4/NLRP3
    Xuliang Huang, Yuhao Zheng, Nan Wang, Mingming Zhao, Jinhui Liu, Wen Lin, Ye Zhu, Xiaofan Xie, Ya Lv, Junlu Wang, Yunchang Mo
    Inflammation.2024;[Epub]     CrossRef
  • The MyoGravity project to study real microgravity effects on human muscle precursor cells and tissue
    Ester Sara Di Filippo, Sara Chiappalupi, Stefano Falone, Vincenza Dolo, Fernanda Amicarelli, Silvia Marchianò, Adriana Carino, Gabriele Mascetti, Giovanni Valentini, Sara Piccirillo, Michele Balsamo, Marco Vukich, Stefano Fiorucci, Guglielmo Sorci, Stefan
    npj Microgravity.2024;[Epub]     CrossRef
  • Mitochondria in skeletal system-related diseases
    Liang Pei, Zhuo Yao, Dong Liang, Keda Yang, Lin Tao
    Biomedicine & Pharmacotherapy.2024; 181: 117505.     CrossRef
  • Incretin-Based Therapies: A Promising Approach for Modulating Oxidative Stress and Insulin Resistance in Sarcopenia
    Raniah I. Alnaser, Fawaz A. Alassaf, Mohammed N. Abed
    Journal of Bone Metabolism.2024; 31(4): 251.     CrossRef
  • Sodium Phenylbutyrate Attenuates Cisplatin-Induced Acute Kidney Injury Through Inhibition of Pyruvate Dehydrogenase Kinase 4
    Chang Joo Oh, Wooyoung Choi, Ha Young Lee, In-Kyu Lee, Min-Ji Kim, Jae-Han Jeon
    Biomedicines.2024; 12(12): 2815.     CrossRef
  • Neuroprotective Effects and Therapeutic Potential of Dichloroacetate: Targeting Metabolic Disorders in Nervous System Diseases
    Yue Zhang, Meiyan Sun, Hongxiang Zhao, Zhengyan Wang, Yanan Shi, Jianxin Dong, Kaifang Wang, Xi Wang, Xingyue Li, Haiyan Qi, Xiaoyong Zhao
    International Journal of Nanomedicine.2023; Volume 18: 7559.     CrossRef
Original Articles
Drug/Regimen
Article image
Effect of Lactobacillus plantarum LMT1-48 on Body Fat in Overweight Subjects: A Randomized, Double-Blind, Placebo-Controlled Trial
Minji Sohn, Hyeyoung Jung, Woo Shun Lee, Tai Hoon Kim, Soo Lim
Diabetes Metab J. 2023;47(1):92-103.   Published online April 29, 2022
DOI: https://doi.org/10.4093/dmj.2021.0370
  • 12,918 View
  • 480 Download
  • 18 Web of Science
  • 19 Crossref
AbstractAbstract PDFSupplementary MaterialPubReader   ePub   
Background
We investigated whether Lactobacillus plantarum strain LMT1-48, isolated from Korean fermented foods and newborn feces, is a suitable probiotic supplement to treat overweight subjects.
Methods
In this randomized, double-blind, placebo-controlled clinical trial, 100 volunteers with a body mass index of 25 to 30 kg/m2 were assigned randomly (1:1) to receive 2×1010 colony forming units of LMT1-48 or to a placebo treatment group. Body composition was measured by dual-energy X-ray absorptiometry, and abdominal visceral fat area (VFA) and subcutaneous fat area were measured by computed tomography scanning. Changes in body fat, VFA, anthropometric parameters, and biomarkers were compared between the two treatment groups (ClinicalTrials.gov number: NCT03759743).
Results
After 12 weeks of treatment, the body weight decreased significantly from 76.6±9.4 to 75.7±9.2 kg in the LMT1-48 group but did not change in the placebo group (P=0.022 between groups). A similar pattern was found in abdominal VFA between the two groups (P=0.041). Serum insulin levels, the corresponding homeostasis model assessment of insulin resistance, and leptin levels decreased in the LMT1-48 group but increased in the placebo group (all P<0.05). Decrease in body weight and body mass index by treatment with LMT1-48 was correlated with increase in Lactobacillus levels significantly. LMT1-48 also increased Oscillibacter levels significantly, which were negatively correlated with triglyceride and alanine transaminase levels.
Conclusion
Administration of LMT1-48 decreased body weight, abdominal VFA, insulin resistance, and leptin levels in these subjects with overweight, suggesting its anti-obesogenic therapeutic potential.

Citations

Citations to this article as recorded by  
  • Advancements in Lactiplantibacillus plantarum : probiotic characteristics, gene editing technologies and applications
    Zhiqi Zhang, Haorui Niu, Qiu Qu, Dingming Guo, Xuchun Wan, Qianqian Yang, Zihao Mo, Siyu Tan, Qian Xiang, Xue Tian, Hongju Yang, Zhi Liu
    Critical Reviews in Food Science and Nutrition.2025; : 1.     CrossRef
  • The therapeutic success of approaches to the gastrointestinal microbiome modulation in the treatment of obesity, metabolic syndrome and type 2 diabetes mellitus
    A. A. Zabolotneva, O. P. Shatova, J. A. Agapova, A. S. Romanenko, S. A. Roumiantsev, A. V. Shestopalov
    Diabetes mellitus.2025; 27(6): 598.     CrossRef
  • Genomic Scale Analysis Foresees Enteroprotective and Butyrogenic Properties in Brazilian Isolates of Lactiplantibacillus plantarum
    Thayra Gomes dos Santos, Karina Araujo Gomes dos Santos, Eddy José Francisco de Oliveira, Bertram Brenig, Elinalva Maciel Paulo, Pedro Henrique Marques, Valbert Nascimento Cardoso, Flávia Figueira Aburjaile, Siomar Castro Soares, Wanderson Marques da Silv
    Probiotics and Antimicrobial Proteins.2025;[Epub]     CrossRef
  • Strain-Specific Therapeutic Potential of Lactiplantibacillus plantarum: A Systematic Scoping Review
    Oranut Chatsirisakul, Natasha Leenabanchong, Yada Siripaopradit, Chun-Wei Chang, Patsakorn Buhngamongkol, Krit Pongpirul
    Nutrients.2025; 17(7): 1165.     CrossRef
  • Beneficial effects of the probiotics and synbiotics supplementation on anthropometric indices and body composition in adults: A systematic review and meta‐analysis
    Saeede Saadati, Kaveh Naseri, Omid Asbaghi, Mohsen Yousefi, Elnaz Golalipour, Barbora de Courten
    Obesity Reviews.2024;[Epub]     CrossRef
  • The Effect of Lactobacillus plantarum on the Fecal Microbiota, Short Chain Fatty Acids, Odorous Substances, and Blood Biochemical Indices of Cats
    Bing Han, Shukun Liang, Jintao Sun, Hui Tao, Zhenlong Wang, Baosheng Liu, Xiumin Wang, Jie Liu, Jinquan Wang
    Microorganisms.2024; 12(1): 91.     CrossRef
  • Natto alleviates hyperlipidemia in high-fat diet-fed mice by modulating the composition and metabolic function of gut microbiota
    Le-Yuan Shang, Shuo Zhang, Min Zhang, Xiao-Dong Sun, Qi Wang, Yu-Jie Liu, Yan-Ni Zhao, Mei Zhao, Peng-Jiao Wang, Xiu-Li Gao
    Journal of Functional Foods.2024; 112: 105968.     CrossRef
  • Microbial-Based Bioactive Compounds to Alleviate Inflammation in Obesity
    Oladayo Emmanuel Apalowo, Grace Adeola Adegoye, Tolulope Mobolaji Obuotor
    Current Issues in Molecular Biology.2024; 46(3): 1810.     CrossRef
  • Anti-obesogenic effects of plant natural products: A focus on Korean traditional foods
    Gitishree Das, Luis Alfonso Jiménez Ortega, Sandra Gonçalves, J. Basilio Heredia, Maria de Lourdes Gomes Pereira, Anabela Romano, Han-Seung Shin, Jayanta Kumar Patra
    Trends in Food Science & Technology.2024; : 104470.     CrossRef
  • A 12-Week, Single-Centre, Randomised, Double-Blind, Placebo-Controlled, Parallel-Design Clinical Trial for the Evaluation of the Efficacy and Safety of Lactiplantibacillus plantarum SKO-001 in Reducing Body Fat
    Seon Mi Shin, Jeong-Su Park, Sang Back Kim, Young Hee Cho, Hee Seo, Hak Sung Lee
    Nutrients.2024; 16(8): 1137.     CrossRef
  • Efficacy and Safety of WCFA19 (Weissella confusa WIKIM51) in Reducing Body Fat in Overweight and Obese Adults
    Hwayeon Sun, Jinyoung Shin, Min-ji Kim, Sunghwan Bae, Nicole Dain Lee, Byungwook Yoo
    Journal of Clinical Medicine.2024; 13(9): 2559.     CrossRef
  • The Role of Lactobacillus plantarum in Reducing Obesity and Inflammation: A Meta-Analysis
    Chen-Pi Li, Chin-Chang Chen, Yao Hsiao, Chieh-Hsin Kao, Chin-Chu Chen, Hao-Jan Yang, Ru-Yin Tsai
    International Journal of Molecular Sciences.2024; 25(14): 7608.     CrossRef
  • Complete genome sequence and anti-obesity potential of Lactiplantibacillus plantarum HOM2217 in 3T3-L1 cells and high-fat diet-fed rats
    Tingting Wang, Xiao Zhang, Linlin Fan, Ying Zhao, Zhengwen Zhang, Zhonghua Cao, Ying Xu, Suwon Lee, Chongyoon Lim, Shiqi Zhang
    Frontiers in Microbiology.2024;[Epub]     CrossRef
  • 3D printing of microencapsulated Lactobacillus rhamnosus for oral delivery
    Pablo Rosas-Val, Masoud Adhami, Ana Brotons-Canto, Carlos Gamazo, Juan M. Irache, Eneko Larrañeta
    International Journal of Pharmaceutics.2023; 641: 123058.     CrossRef
  • Gut commensal Kineothrix alysoides mitigates liver dysfunction by restoring lipid metabolism and gut microbial balance
    Kyoung Jin Choi, Mi Young Yoon, Ji-Eun Kim, Sang Sun Yoon
    Scientific Reports.2023;[Epub]     CrossRef
  • Ameliorating Effects of Bifidobacterium longum subsp. infantis FB3-14 against High-Fat-Diet-Induced Obesity and Gut Microbiota Disorder
    Ruixin Kou, Jin Wang, Ang Li, Yuanyifei Wang, Bowei Zhang, Jingmin Liu, Yi Sun, Shuo Wang
    Nutrients.2023; 15(19): 4104.     CrossRef
  • Effect of Continuous Ingestion of Bifidobacteria and Inulin on Reducing Body Fat: A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Comparison Study
    Yuhei Baba, Yasuo Saito, Mei Kadowaki, Naoki Azuma, Daisuke Tsuge
    Nutrients.2023; 15(24): 5025.     CrossRef
  • A Review of the Potential of Probiotic Bacteria in Managing the Body Weight of Obese Individuals
    A Didban, L Manafi, R Mahmoudi
    Journal of Health and Hygiene.2023; 14(4): 388.     CrossRef
  • Plant-Derived Lactobacillus paracasei IJH-SONE68 Improves the Gut Microbiota Associated with Hepatic Disorders: A Randomized, Double-Blind, and Placebo-Controlled Clinical Trial
    Narandalai Danshiitsoodol, Masafumi Noda, Keishi Kanno, Tomoyuki Uchida, Masanori Sugiyama
    Nutrients.2022; 14(21): 4492.     CrossRef
Guideline/Fact Sheet
Article image
Dyslipidemia Fact Sheet in South Korea, 2022
Eun-Sun Jin, Jee-Seon Shim, Sung Eun Kim, Jae Hyun Bae, Shinae Kang, Jong Chul Won, Min-Jeong Shin, Heung Yong Jin, Jenny Moon, Hokyou Lee, Hyeon Chang Kim, In-Kyung Jeong, on Behalf of the Committee of Public Relation of the Korean Society of Lipid and Atherosclerosis
Diabetes Metab J. 2023;47(5):632-642.   Published online August 2, 2023
DOI: https://doi.org/10.4093/dmj.2023.0135
  • 12,767 View
  • 508 Download
  • 14 Web of Science
  • 18 Crossref
AbstractAbstract PDFSupplementary MaterialPubReader   ePub   
Background
This study aimed to investigate the prevalence and status of dyslipidemia management among South Korean adults, as performed by the Korean Society of Lipid and Atherosclerosis under the name Dyslipidemia Fact Sheet 2022.
Methods
We analyzed the lipid profiles, age-standardized and crude prevalence, management status of hypercholesterolemia and dyslipidemia, and health behaviors among Korean adults aged ≥20 years, using the Korea National Health and Nutrition Examination Survey data between 2007 and 2020.
Results
In South Korea, the crude prevalence of hypercholesterolemia (total cholesterol ≥240 mg/dL or use of a lipid-lowering drug) in 2020 was 24%, and the age-standardized prevalence of hypercholesterolemia more than doubled from 2007 to 2020. The crude treatment rate was 55.2%, and the control rate was 47.7%. The crude prevalence of dyslipidemia—more than one out of three conditions (low-density lipoprotein cholesterol ≥160 or the use of a lipid-lowering drug, triglycerides ≥200, or high-density lipoprotein cholesterol [HDL-C] [men and women] <40 mg/dL)—was 40.2% between 2016 and 2020. However, it increased to 48.2% when the definition of hypo-HDL-cholesterolemia in women changed from <40 to <50 mg/dL.
Conclusion
Although the prevalence of hypercholesterolemia and dyslipidemia has steadily increased in South Korea, the treatment rate remains low. Therefore, continuous efforts are needed to manage dyslipidemia through cooperation between the national healthcare system, patients, and healthcare providers.

Citations

Citations to this article as recorded by  
  • Big Data Research for Diabetes-Related Diseases Using the Korean National Health Information Database
    Kyung-Soo Kim, Bongseong Kim, Kyungdo Han
    Diabetes & Metabolism Journal.2025; 49(1): 13.     CrossRef
  • Automated process assessment of primary healthcare for hyperlipidemia: preliminary findings and implications form Anhui, China
    Ningjing Yang, Yuning Wang, Ying Li, Dongying Xiao, Ruirui Cui, Nana Li, Rong Liu, Jing Chai, Xingrong Shen, Debin Wang
    Lipids in Health and Disease.2025;[Epub]     CrossRef
  • Persistently Active Helicobacter pylori Infection Is Associated with the Development of Metabolic Dysfunction-Associated Steatotic Liver Disease
    Jun Young Kim, Byung Soo Kwan, Jung Hwan Cho, Hye In Kim, Nak Gyeong Ko, Mihyeon Jin, Ok Jae Lee
    Journal of Clinical Medicine.2025; 14(4): 1073.     CrossRef
  • Older Adults with Diabetes in Korea: Latest Clinical and Epidemiologic Trends
    Kyuho Kim, Bongseong Kim, Kyuna Lee, Yu-Bae Ahn, Seung-Hyun Ko, Sung Hee Choi, Kyungdo Han, Jae-Seung Yun
    Diabetes & Metabolism Journal.2025; 49(2): 183.     CrossRef
  • Comparing non-alcoholic fatty liver disease indices in predicting the prevalence and incidence of metabolic syndrome in middle-aged adults
    Byung Sik Kim, Hyun-Jin Kim, Seong Won Jeon, Kyung Hwan Kim, Dong Wook Kim, Jeong-Hun Shin
    Heliyon.2025; 11(7): e43073.     CrossRef
  • Current Status of Development of Oral Formulations Combining Omega-3 Fatty Acids and Statin Ingredients and Prospects for New Formulations
    Ji-Hun Jang, Seung-Hyun Jeong
    Journal of Pharmaceutical Innovation.2025;[Epub]     CrossRef
  • A Scoring Model Using Multi-Metabolites Based on Untargeted Metabolomics for Assessing Dyslipidemia in Korean Individuals with Obesity
    Su-Geun Yang, Hye Jin Yoo
    Metabolites.2025; 15(4): 279.     CrossRef
  • Addressing Cardiovascular Diseases Challenges in South Korea: Strategies to Improve Outcomes
    Hyun-Jae Kang, JuMee Wang, Eun Joo Cho, Hack- Lyoung Kim, Chan Joo Lee, Jae Hyoung Park, Jeehoon Kang, Jon Suh, Ki Hong Choi, Seung-Yul Lee, Jong-Il Choi, Il-young Oh, Ungjeong Do, Seung Young Roh, Sang-Ho Jo, Jin Wi, Dae-Hwan Bae, Mi-Hyang Jung, Chan Seo
    Korean Circulation Journal.2025;[Epub]     CrossRef
  • Oxidative Balance Score and New-Onset Type 2 Diabetes Mellitus in Korean Adults without Non-Alcoholic Fatty Liver Disease: Korean Genome and Epidemiology Study-Health Examinees (KoGES-HEXA) Cohort
    Mid-Eum Moon, Dong Hyuk Jung, Seok-Jae Heo, Byoungjin Park, Yong Jae Lee
    Antioxidants.2024; 13(1): 107.     CrossRef
  • Comparison of metabolic and neurological comorbidities in Asian patients with psoriasis and atopic dermatitis
    Hee Joo Yang, Mi Young Lee, Jeong Hyeon Lee, Chang Jin Jung, Woo Jin Lee, Chong Hyun Won, Mi Woo Lee, Joon Min Jung, Sung Eun Chang
    Scientific Reports.2024;[Epub]     CrossRef
  • Effect of Adding Apolipoprotein B Testing on the Prevalence of Dyslipidemia and Risk of Cardiovascular Disease in the Korean Adult Population
    Rihwa Choi, Sang Gon Lee, Eun Hee Lee
    Metabolites.2024; 14(3): 169.     CrossRef
  • Body Weight Variability and Risk of Suicide Mortality: A Nationwide Population-Based Study
    Jeongmin Lee, Jin-Hyung Jung, Dong Woo Kang, Min-Hee Kim, Dong-Jun Lim, Hyuk-Sang Kwon, Jung Min Lee, Sang-Ah Chang, Kyungdo Han, Seung-Hwan Lee, Fuquan Zhang
    Depression and Anxiety.2024; 2024: 1.     CrossRef
  • Association of atherosclerosis indices, serum uric acid to high‐density lipoprotein cholesterol ratio and triglycerides‐glucose index with hypertension: A gender‐disaggregated analysis
    Rana Kolahi Ahari, Toktam Sahranavard, Amin Mansoori, Zahra Fallahi, Negin Babaeepoor, Gordon Ferns, Majid Ghayour‐Mobarhan
    The Journal of Clinical Hypertension.2024; 26(6): 645.     CrossRef
  • A Machine Learning Approach to Identify of Dyslipidemia based on Body Composition Indices in Men
    Mi Hong Yim, Sanghun Lee
    The Journal of Korean Institute of Information Technology.2024; 22(6): 153.     CrossRef
  • Association of aerobic and muscle-strengthening physical activity with chronic kidney disease in participants with hypertension
    Yunmin Han, Younghwan Choi, Yeon Soo Kim
    Clinical Hypertension.2024;[Epub]     CrossRef
  • Recent trends of low-density lipoprotein cholesterol control and lipid-lowering therapy in patients with atherosclerotic cardiovascular disease in Taiwan: 2015–2020
    Tzu-Yang Chen, Yu-Chung Hsiao, Yen-Wen Wu, Tsung-Hsien Lin, Wayne Huey-Herng Sheu, Thung-Lip Lee, I-Chang Hsieh, Yi-Heng Li, Wei-Hsian Yin, Hung-I Yeh, Jaw-Wen Chen, Fang-Ju Lin, Chau-Chung Wu
    Journal of the Formosan Medical Association.2024;[Epub]     CrossRef
  • Study Design and Protocol for a Randomized Controlled Trial to Assess Long-Term Efficacy and Safety of a Triple Combination of Ezetimibe, Fenofibrate, and Moderate-Intensity Statin in Patients with Type 2 Diabetes and Modifiable Cardiovascular Risk Factor
    Nam Hoon Kim, Juneyoung Lee, Suk Chon, Jae Myung Yu, In-Kyung Jeong, Soo Lim, Won Jun Kim, Keeho Song, Ho Chan Cho, Hea Min Yu, Kyoung-Ah Kim, Sang Soo Kim, Soon Hee Lee, Chong Hwa Kim, Soo Heon Kwak, Yong‐ho Lee, Choon Hee Chung, Sihoon Lee, Heung Yong J
    Endocrinology and Metabolism.2024; 39(5): 722.     CrossRef
  • Exploring Utilization and Establishing Reference Intervals for the Apolipoprotein B Test in the Korean Population
    Rihwa Choi, Sang Gon Lee, Eun Hee Lee
    Diagnostics.2023; 13(20): 3194.     CrossRef
Reviews
Basic Research
Article image
Regulation of Cellular Senescence in Type 2 Diabetes Mellitus: From Mechanisms to Clinical Applications
Kanako Iwasaki, Cristian Abarca, Cristina Aguayo-Mazzucato
Diabetes Metab J. 2023;47(4):441-453.   Published online March 6, 2023
DOI: https://doi.org/10.4093/dmj.2022.0416
  • 10,133 View
  • 609 Download
  • 17 Web of Science
  • 18 Crossref
AbstractAbstract PDFPubReader   ePub   
Cellular senescence is accelerated by hyperglycemia through multiple pathways. Therefore, senescence is an important cellular mechanism to consider in the pathophysiology of type 2 diabetes mellitus (T2DM) and an additional therapeutic target. The use of drugs that remove senescent cells has led to improvements in blood glucose levels and diabetic complications in animal studies. Although the removal of senescent cells is a promising approach for the treatment of T2DM, two main challenges limit its clinical application: the molecular basis of cellular senescence in each organ is yet to be understood, and the specific effect of removing senescent cells in each organ has to be determined. This review aims to discuss future applications of targeting senescence as a therapeutic option in T2DM and elucidate the characteristics of cellular senescence and senescence-associated secretory phenotype in the tissues important for regulating glucose levels: pancreas, liver, adipocytes, and skeletal muscle.

Citations

Citations to this article as recorded by  
  • AQP1 mediates pancreatic β cell senescence induced by metabolic stress through modulating intracellular H2O2 level
    Qihui Yan, Haifeng Zhang, Yunxiao Ma, Lin Sun, Zhiyue Chen, Yinbei Zhang, Weiying Guo
    Free Radical Biology and Medicine.2025; 226: 171.     CrossRef
  • Targeting the hypothalamic MC4 receptor: A novel approach to senolytic therapy?
    Youn Ju Kim, Joo Hyun Lim, Eun Ran Kim
    Medical Hypotheses.2025; 195: 111551.     CrossRef
  • Bcl-2 and Bcl-xL in Diabetes: Contributions to Endocrine Pancreas Viability and Function
    Atenea A. Perez-Serna, Daniel Guzman-Llorens, Reinaldo S. Dos Santos, Laura Marroqui
    Biomedicines.2025; 13(1): 223.     CrossRef
  • Cellular Senescence in Health, Disease, and Lens Aging
    Ying Qin, Haoxin Liu, Hongli Wu
    Pharmaceuticals.2025; 18(2): 244.     CrossRef
  • Recent Advances in Anti‐Aging Therapeutic Strategies Targeting DNA Damage Response and Senescence‐Associated Secretory Phenotype‐Linked Signaling Cascade
    Jawad Nadeem, Razia Sultana, Amna Parveen, Sun Yeou Kim
    Cell Biochemistry and Function.2025;[Epub]     CrossRef
  • Anti-senescence therapies: a new concept to address cardiovascular disease
    Stevan D Stojanović, Thomas Thum, Johann Bauersachs
    Cardiovascular Research.2025;[Epub]     CrossRef
  • Amide Alkaloids as Privileged Sources of Senomodulators for Therapeutic Purposes in Age-Related Diseases
    Mazzarine Dotou, Aurore L’honoré, Roba Moumné, Chahrazade El Amri
    Journal of Natural Products.2024; 87(3): 617.     CrossRef
  • Study on the Pathogenesis of Cell Senescence in Non-Alcoholic Fatty Liver
    丽媛 黄
    Medical Diagnosis.2024; 14(01): 76.     CrossRef
  • Senescent adipocytes and type 2 diabetes – current knowledge and perspective concepts
    Weronika Kruczkowska, Julia Gałęziewska, Mateusz Kciuk, Adrianna Gielecińska, Elżbieta Płuciennik, Zbigniew Pasieka, Lin-Yong Zhao, Yi-Jin Yu, Damian Kołat, Żaneta Kałuzińska-Kołat
    Biomolecular Concepts.2024;[Epub]     CrossRef
  • New Molecules in Type 2 Diabetes: Advancements, Challenges and Future Directions
    Kyriazoula Chatzianagnostou, Melania Gaggini, Adrian Suman Florentin, Ludovica Simonini, Cristina Vassalle
    International Journal of Molecular Sciences.2024; 25(11): 6218.     CrossRef
  • Benefits of Quercetin on Glycated Hemoglobin, Blood Pressure, PiKo-6 Readings, Night-Time Sleep, Anxiety, and Quality of Life in Patients with Type 2 Diabetes Mellitus: A Randomized Controlled Trial
    Aikaterini E. Mantadaki, Manolis Linardakis, Maria Tsakiri, Stella Baliou, Persefoni Fragkiadaki, Elena Vakonaki, Manolis N. Tzatzarakis, Aristidis Tsatsakis, Emmanouil K. Symvoulakis
    Journal of Clinical Medicine.2024; 13(12): 3504.     CrossRef
  • Insulin Resistance in Women Correlates with Chromatin Histone Lysine Acetylation, Inflammatory Signaling, and Accelerated Aging
    Christina M. Vidal, Jackelyn A. Alva-Ornelas, Nancy Zhuo Chen, Parijat Senapati, Jerneja Tomsic, Vanessa Myriam Robles, Cristal Resto, Nancy Sanchez, Angelica Sanchez, Terry Hyslop, Nour Emwas, Dana Aljaber, Nick Bachelder, Ernest Martinez, David Ann, Ver
    Cancers.2024; 16(15): 2735.     CrossRef
  • Quercetin Intake and Absolute Telomere Length in Patients with Type 2 Diabetes Mellitus: Novel Findings from a Randomized Controlled Before-and-After Study
    Aikaterini E. Mantadaki, Stella Baliou, Manolis Linardakis, Elena Vakonaki, Manolis N. Tzatzarakis, Aristides Tsatsakis, Emmanouil K. Symvoulakis
    Pharmaceuticals.2024; 17(9): 1136.     CrossRef
  • Body Composition and Senescence: Impact of Polyphenols on Aging-Associated Events
    Tanila Wood dos Santos, Quélita Cristina Pereira, Isabela Monique Fortunato, Fabrício de Sousa Oliveira, Marisa Claudia Alvarez, Marcelo Lima Ribeiro
    Nutrients.2024; 16(21): 3621.     CrossRef
  • Loxenatide Alleviates High Glucose-Induced Pancreatic β-Cell Senescence via Regulating the PERK/eIF2α Pathway
    Junfang Yuan, Yuzhong Wang, Defeng Wang, Han Yan, Ning Wang
    Hormone and Metabolic Research.2024; 56(12): 890.     CrossRef
  • Insulin Sensitivity Controls Activity of Pathogenic CD4+ T Cells in Rheumatoid Arthritis
    Malin C. Erlandsson, Eric Malmhäll-Bah, Venkataragavan Chandrasekaran, Karin M. E. Andersson, Lisa M. Nilsson, Sofia Töyrä Silfverswärd, Rille Pullerits, Maria I. Bokarewa
    Cells.2024; 13(24): 2124.     CrossRef
  • The Effect of Long-Term Passage on Porcine SMCs’ Function and the Improvement of TGF-β1 on Porcine SMCs’ Secretory Function in Late Passage
    Yan-Yan Zheng, Ze-Nan Hu, Zheng Liu, Yi-Chen Jiang, Ren-Peng Guo, Shi-Jie Ding, Guang-Hong Zhou
    Foods.2023; 12(14): 2682.     CrossRef
  • Exploring the Relationship between Cellular Senescence Markers and Aging-Related Diseases
    怡 罗
    Advances in Clinical Medicine.2023; 13(08): 12298.     CrossRef
Pathophysiology
Article image
Immune-Checkpoint Inhibitors-Induced Type 1 Diabetes Mellitus: From Its Molecular Mechanisms to Clinical Practice
Yun Kyung Cho, Chang Hee Jung
Diabetes Metab J. 2023;47(6):757-766.   Published online July 24, 2023
DOI: https://doi.org/10.4093/dmj.2023.0072
  • 7,973 View
  • 562 Download
  • 13 Web of Science
  • 17 Crossref
AbstractAbstract PDFPubReader   ePub   
With the increasing use of immune-checkpoint inhibitors (ICIs), such as anti-cytotoxic T lymphocyte-associated antigen 4 (CTLA-4) and anti-programmed cell death-1 (PD-1), for the treatment of malignancies, cases of ICI-induced type 1 diabetes mellitus (ICI-T1DM) have been reported globally. This review focuses on the features and pathogenesis of this disease. T1DM is an immune-related adverse event that occurs following the administration of anti-PD-1 or anti-programmed death ligand-1 (PDL1) alone or in combination with anti-CTLA-4. More than half of the reported cases presented as abrupt-onset diabetic ketoacidosis. The primary mechanism of ICI-T1DM is T-cell stimulation, which results from the loss of interaction between PD-1 and PD-L1 in pancreatic islet. The similarities and differences between ICI-T1DM and classical T1DM may provide insights into this disease entity. ICI-T1DM is a rare but often life-threatening medical emergency that healthcare professionals and patients need to be aware of. Early detection of and screening for this disease is imperative. At present, the only known treatment for ICI-T1DM is insulin injection. Further research into the mechanisms and risk factors associated with ICI-T1DM development may contribute to a better understanding of this disease entity and the identification of possible preventive strategies.

Citations

Citations to this article as recorded by  
  • Diabetic ketoacidosis and hyperglycaemic hyperosmolar syndrome in patients with cancer: A multicentre study
    Rabia K. Shahid, Qasem Haider, Sunil Yadav, Duc Le, Shahid Ahmed
    Clinical Medicine.2025; 25(1): 100262.     CrossRef
  • Immune checkpoint inhibitor‐related type 1 diabetes incidence, risk, and survival association
    Fumika Kamitani, Yuichi Nishioka, Miyuki Koizumi, Hiroki Nakajima, Yukako Kurematsu, Sadanori Okada, Shinichiro Kubo, Tomoya Myojin, Tatsuya Noda, Tomoaki Imamura, Yutaka Takahashi
    Journal of Diabetes Investigation.2025; 16(2): 334.     CrossRef
  • Management of Immunotherapy-Induced Type 1 Diabetes
    Veronica Brady
    Critical Care Nursing Clinics of North America.2025; 37(1): 93.     CrossRef
  • Type I Diabetes—A Rare Adverse Event Described in Patients Receiving Immunotherapy Versus a Side Effect from SARS-CoV-2 Infection
    Raluca-Ileana Pătru, Miruna Ghigeanu, Maria-Alexandra Barbu, Andreea Iuliana Ionescu, Antone-Iordache Ionuț-Lucian
    Reports.2025; 8(1): 31.     CrossRef
  • Immune Checkpoint Inhibitor-Induced Pancreatic Injury (ICI-PI) in Adult Cancer Patients: A Systematic Review and Meta-Analysis
    Cha Len Lee, Israt Jahan Riya, Ifrat Jahan Piya, Thiago Pimentel Muniz, Marcus Otho Butler, Samuel David Saibil
    Cancers.2025; 17(7): 1080.     CrossRef
  • Cemiplimab and diabetic ketoacidosis: a case report of a rare endocrinopathy associated with immune checkpoint inhibitors
    Anna Arecco, Cristian Petolicchio, Alessandro Pastorino, Enrica Teresa Tanda, Lara Vera, Mara Boschetti, Francesco Cocchiara, Davide Carlo Maggi, Diego Ferone, Federico Gatto
    Frontiers in Endocrinology.2025;[Epub]     CrossRef
  • Efficacy and adverse events of immune checkpoint inhibitors: evidence from non-small cell lung cancer and gastric cancer in Korea and Japan
    Mc Neil Valencia, Zeeshan Abbas, Seung Won Lee
    Precision and Future Medicine.2025; 9(1): 15.     CrossRef
  • Durvalumab‑induced type 1 diabetes mellitus in lung adenocarcinoma: A case report and literature review
    Huijing Dong, Shengfu Li, Yanmei Peng, Xu Zhang, Jiabin Zheng, Chongxiang Xue, Yumin Zheng, Yixuan Yu, Xingyu Lu, Zixin Hu, Huijuan Cui
    Oncology Letters.2025; 29(6): 1.     CrossRef
  • Research Advances of Immune Checkpoint Inhibitors Related Endocrine Adverse Events
    晶晶 王
    Advances in Clinical Medicine.2024; 14(02): 2706.     CrossRef
  • Immune checkpoint inhibitor‑associated diabetes mellitus in patients with HCC: Report of three cases and literature review
    Gaocheng Wang, Jingjing Wang, Shuilin Dong, Zhanguo Zhang, Wanguang Zhang, Jianping Zhao
    Experimental and Therapeutic Medicine.2024;[Epub]     CrossRef
  • Type 1 diabetes: immune pathology and novel therapeutic approaches
    Eleanor M. Ling, Joana R. N. Lemos, Khemraj Hirani, Matthias von Herrath
    Diabetology International.2024; 15(4): 761.     CrossRef
  • Pathophysiology, diagnosis, and management of immune checkpoint inhibitor-induced diabetes mellitus
    Eleni-Rafaela Kani, Eleftheria Karaviti, Dimitra Karaviti, Eleni Gerontiti, Ioanna A. Paschou, Katerina Saltiki, Katerina Stefanaki, Theodora Psaltopoulou, Stavroula A. Paschou
    Endocrine.2024; 87(3): 875.     CrossRef
  • Use pembrolizumab may cause acute and severe adverse reactions: a case report and review
    Linna Ouyang, Huixing Liu, Zhixiang Tang, Rui Wu, Yujie Zhong, Haibin Chen
    International Journal of Surgery Oncology.2024; 9(3): 40.     CrossRef
  • Pembrolizumab-Induced Insulin-Dependent Diabetes Mellitus in a Patient With Triple-Negative Breast Cancer: A Rare Immune-Related Adverse Event
    Mirac Burak Tak, Zaid Munir, Ahmet Aydin
    Cureus.2024;[Epub]     CrossRef
  • Diabetes and the associated complications: The role of antioxidants in diabetes therapy and care
    Lowell Dilworth, Dewayne Stennett, Aldeam Facey, Felix Omoruyi, Shada Mohansingh, Felix O. Omoruyi
    Biomedicine & Pharmacotherapy.2024; 181: 117641.     CrossRef
  • Fulminant type 1 diabetes mellitus: a neglected but high-risk adverse event associated with immune checkpoint inhibitors
    Kelin Meng, Shengling Fu, Yaochen Huang, Wei Chen, Wenbin Zou
    Expert Opinion on Drug Safety.2024; : 1.     CrossRef
  • Fulminant Type 1 Diabetes Mellitus Leading to Diabetic Ketoacidosis and Mesenteric Ischemia With Necrosis Following Pembrolizumab Administration: A Case Report
    Mayu Ueki, Takeshi Fukuda, Kenta Oue, Takuma Wada, Toshiyuki Sumi
    Cureus.2024;[Epub]     CrossRef
Original Article
Metabolic Risk/Epidemiology
Article image
Metabolic Dysfunction-Associated Fatty Liver Disease and Mortality: A Population-Based Cohort Study
Kyung-Soo Kim, Sangmo Hong, Hong-Yup Ahn, Cheol-Young Park
Diabetes Metab J. 2023;47(2):220-231.   Published online January 12, 2023
DOI: https://doi.org/10.4093/dmj.2021.0327
  • 65,535 View
  • 341 Download
  • 17 Web of Science
  • 17 Crossref
AbstractAbstract PDFSupplementary MaterialPubReader   ePub   
Background
We investigated whether metabolic dysfunction-associated fatty liver disease (MAFLD) is associated with an elevated risk of all-cause and cardiovascular mortality using a large-scale health examination cohort.
Methods
A total of 394,835 subjects in the Kangbuk Samsung Health Study cohort were enrolled from 2002 to 2012. Participants were categorized by the presence of nonalcoholic fatty liver disease (NAFLD) and MAFLD as follows: normal subjects; patients with both NAFLD and MAFLD; patients with NAFLD only; and patients with MAFLD only. Cox proportional hazards models were used to analyze the risk of mortality.
Results
During a median 5.7 years of follow-up, 20.69% was patients with both NAFLD and MAFLD, 1.51% was patients with NAFLD only, and 4.29% was patients with MAFLD only. All-cause and cardiovascular death was higher in patients with MAFLD than those without MAFLD (P<0.001, respectively). In patients with MAFLD only, the hazard ratio (HR) of all-cause and cardiovascular death was 1.35 (95% confidence interval [CI], 1.13 to 1.60) and 1.90 (95% CI, 1.26 to 2.88) after adjusting for age, which lost its statistical significance by multivariable adjustments. Compared to patients with less than two components of metabolic dysfunction, patients with more than two components of metabolic dysfunction were a higher risk of cardiovascular death (HR, 2.05; 95% CI, 1.25 to 3.38) and only women with more than two components of metabolic dysfunction were a higher risk of all-cause death (HR, 1.44; 95% CI, 1.02 to 2.03).
Conclusion
MAFLD criteria could identify a high-risk group for all-cause and cardiovascular death.

Citations

Citations to this article as recorded by  
  • Research Progress of the Relationship between Metabolic-Associated Fatty Liver Disease and Colorectal Neoplasia
    杨 包
    Advances in Clinical Medicine.2025; 15(02): 1996.     CrossRef
  • Mortality in metabolic dysfunction-associated steatotic liver disease: A nationwide population-based cohort study
    Eugene Han, Byung-Wan Lee, Eun Seok Kang, Bong-Soo Cha, Sang Hoon Ahn, Yong-ho Lee, Seung Up Kim
    Metabolism.2024; 152: 155789.     CrossRef
  • Association of non-alcoholic fatty liver disease with cardiovascular disease and all cause death in patients with type 2 diabetes mellitus: nationwide population based study
    Kyung-Soo Kim, Sangmo Hong, Kyungdo Han, Cheol-Young Park
    BMJ.2024; : e076388.     CrossRef
  • Sex differences in mortality and liver‐related events in non‐alcoholic fatty liver disease: A systematic review and meta‐analysis
    Huimin Zhou, Haiyan Chen, Hanxiao Lu, Bo Wu, Shuo Zhang, Yuanlong Gu, Guangwen Zhou, Jie Xiang, Jun Yang
    Liver International.2024; 44(7): 1600.     CrossRef
  • Association between dietary carbohydrate to fiber ratio and metabolic dysfunction associated fatty liver disease in adults: evidence from the NHANES 2017–2020
    Zhenmin Liu, Taiyong Fang
    Journal of Health, Population and Nutrition.2024;[Epub]     CrossRef
  • NAFLD and MAFLD independently increase the risk of major adverse cardiovascular events (MACE): a 20-year longitudinal follow-up study from regional Australia
    Karl Vaz, William Kemp, Ammar Majeed, John Lubel, Dianna J. Magliano, Kristen M. Glenister, Lisa Bourke, David Simmons, Stuart K. Roberts
    Hepatology International.2024; 18(4): 1135.     CrossRef
  • Clinical outcomes of MAFLD versus NAFLD: A meta‐analysis of observational studies
    Grazia Pennisi, Giuseppe Infantino, Ciro Celsa, Gabriele Di Maria, Marco Enea, Marco Vaccaro, Roberto Cannella, Carlo Ciccioli, Claudia La Mantia, Alessandro Mantovani, Francesco Mercurio, Herbert Tilg, Giovanni Targher, Vito Di Marco, Calogero Cammà, Sal
    Liver International.2024; 44(11): 2939.     CrossRef
  • Racial and ethnic disparities in metabolic dysfunction-associated steatotic liver disease outcomes: A call for culturally sensitive interventions: Editorial on “Differences in liver and mortality outcomes of non-alcoholic fatty liver disease by race and e
    Jae Hyun Bae
    Clinical and Molecular Hepatology.2024; 30(4): 665.     CrossRef
  • Metabolic Dysfunction-Associated Steatotic Liver Disease in Type 2 Diabetes Mellitus: A Review and Position Statement of the Fatty Liver Research Group of the Korean Diabetes Association
    Jaehyun Bae, Eugene Han, Hye Won Lee, Cheol-Young Park, Choon Hee Chung, Dae Ho Lee, Eun-Hee Cho, Eun-Jung Rhee, Ji Hee Yu, Ji Hyun Park, Ji-Cheol Bae, Jung Hwan Park, Kyung Mook Choi, Kyung-Soo Kim, Mi Hae Seo, Minyoung Lee, Nan-Hee Kim, So Hun Kim, Won-
    Diabetes & Metabolism Journal.2024; 48(6): 1015.     CrossRef
  • MAFLD but not MASLD increases risk of all-cause mortality in regional Australia, with components of metabolic syndrome exacerbating factors: 20 year longitudinal, cohort study
    Karl Vaz, William Kemp, Ammar Majeed, John Lubel, Dianna J. Magliano, Kristen M. Glenister, Lisa Bourke, David Simmons, Stuart K. Roberts
    Hepatology International.2024;[Epub]     CrossRef
  • Cumulative Burden of Fatty Liver and Kidney Cancer in Young Men: A National Population-Based Study
    Hee Yeon Lee, Kyung Do Han, Hyuk-Sang Kwon
    Journal of Clinical Medicine.2024; 14(1): 148.     CrossRef
  • Comparison of Outcomes Between Metabolic Dysfunction-Associated Fatty Liver Disease and Non-alcoholic Fatty Liver Disease: A Meta-Analysis
    Ghazala S Virk, Jaahnavi Vajje, Nausheen K Virk, Raam Mannam, Wajeeh Rehman, Naglaa G Ghobriel , Irfan-ud-din Mian, Muhammad Usama
    Cureus.2023;[Epub]     CrossRef
  • Trends in prevalence and all-cause mortality of metabolic dysfunction-associated fatty liver disease among adults in the past three decades: Results from the NHANES study
    Zhi-Qin Xie, Hong-Xia Li, Bing-Kun Wang, Zhao-Ming Yang, Zi-Yu Zhang, Wen-Liang Tan, Wen-Xin Li, Qing-Bin Wang, Lei Yang, Hong-Kai Zhuang, Chen-Wei Tang, Chang-Zhen Shang, Ya-Jin Chen
    European Journal of Internal Medicine.2023; 110: 62.     CrossRef
  • Comparing the Mortality Risk between Metabolic Dysfunction-Associated Fatty Liver Disease and Non-Alcoholic Fatty Liver Disease
    Han Na Jung, Chang Hee Jung
    Diabetes & Metabolism Journal.2023; 47(2): 198.     CrossRef
  • Increased expression of sodium-glucose cotransporter 2 and O-GlcNAcylation in hepatocytes drives non-alcoholic steatohepatitis
    Hye Jin Chun, Eun Ran Kim, Minyoung Lee, Da Hyun Choi, Soo Hyun Kim, Eugene Shin, Jin-Hong Kim, Jin Won Cho, Dai Hoon Han, Bong-Soo Cha, Yong-ho Lee
    Metabolism.2023; 145: 155612.     CrossRef
  • Current understanding and future perspectives on the impact of changing NAFLD to MAFLD on global epidemiology and clinical outcomes
    Karl Vaz, Daniel Clayton-Chubb, Ammar Majeed, John Lubel, David Simmons, William Kemp, Stuart K. Roberts
    Hepatology International.2023; 17(5): 1082.     CrossRef
  • Mitochondrial Quality Control: Its Role in Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)
    Soyeon Shin, Jaeyoung Kim, Ju Yeon Lee, Jun Kim, Chang-Myung Oh
    Journal of Obesity & Metabolic Syndrome.2023; 32(4): 289.     CrossRef

Diabetes Metab J : Diabetes & Metabolism Journal
Close layer
TOP